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Advisor: Edgar Cahoon 
 Sphingolipids are a structurally diverse group of lipids recognized as important 
components of cellular membranes and regulators of processes during development and 
in response to environmental stresses. Much progress has been made characterizing the 
enzymes of the biosynthetic pathway revealing that sphingolipids are essential molecules 
in plants and that their synthesis and degradation needs to be tightly regulated. Serine 
palmitoyltransferase (SPT) catalyzes the first step in sphingolipid biosynthesis and is a 
primary regulatory point for homeostasis. ORM proteins have been identified as negative 
regulators of SPT activity, however the mechanistic details of the regulation and other 
functional roles of these proteins are only beginning to be understood. In this work, we 
show that ORM1 and ORM2 are essential for life cycle completion in Arabidopsis 
thaliana. Through the characterization of ORM gene-edited mutants we described that 
unregulated sphingolipid biosynthesis resulted in ceramide hyperaccumulation, altered 
organellar structures and increased senescence- and pathogenesis-related gene 
expression. Furthermore, the study of a structural ORM1 variant provided information 
about a transmembrane domain involved in the interaction with SPT.  
In this thesis, we also provide insights into the physiological effects caused by 
mutations in SPT that induce the production of deoxysphingolipids. Our research 
 
 
demonstrates that plants expressing these mutations showed early senescence and 
reduced sensitivity to the cell death induced by Fumonisin B1. These findings suggest 
functional roles of deoxysphingolipids that have not been explored in plants.  
Finally, we describe a labeling approach to build a sphingolipid kinetic model to 
study the metabolic flux of sphingolipids during pathogen infection. This study considers 
a more comprehensive view of the sphingolipid metabolic network that changes 
dynamically when perturbed.  
Overall, this study encompasses several aspects of sphingolipid biology in plants. 
From a directed understanding of the regulatory mechanism and how enzyme variants 
can lead to the synthesis of atypical sphingolipids to a more comprehensive 
understanding of the metabolic network. The combination of these approaches will 
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1 Chapter 1 Introduction 
1. Sphingolipids 
Sphingolipids are a ubiquitously distributed and diverse class of lipids that can be 
found in eukaryotic organisms and in some bacteria genus. Their amphiphilic nature 
given by a polar head group and two hydrophobic acyl chains make sphingolipids, along 
with glycerophospholipids and sterols, structural components of cellular membranes 
including plasma membrane (PM), endoplasmic reticulum (ER), Golgi apparatus, 
mitochondria and vacuole membranes (Moreau et al., 1998). Crucial physiological 
processes that take place at the PM are mediated by glycosphingolipids that can form 
platforms for the organization and function of proteins involved in stimulus perception, 
signal transduction, protein translocation, endocytosis and cytoskeletal organization 
(Kraft et al, 2017; Laloi et al., 2007; Mongrand et al., 2004). Moreover, in plants, these 
glycosphingolipids enriched in the outer leaflet of the PM function as receptors of toxins 
produced by pathogens and are involved in sensing salt associated with environmental 
ionic stress (Jian et al., 2019; Lenarcic et al., 2017). Beyond their function as membrane 
components and receptors, other sphingolipid species play crucial roles as signaling 
molecules orchestrating environmental responses. Several reports have documented the 
roles of sphingolipids in response to drought, low temperatures, pathogenicity and as 
triggers of programed cell death and autophagy (Dutilleul et al., 2015; Huby et al., 2020; 
Magnin-Robert et al., 2015).  In the last decades, a huge progress has been done in the 
plant sphingolipid biology field understanding the biosynthetic pathway and the functions 
of sphingolipid species in development and response to the environment. This knowledge 
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has opened new routes to discover how the cells sense sphingolipids levels and regulate 
the biosynthetic pathway in response to specific needs.   
1.1.1 Sphingolipid Biosynthesis  
In general, there is broad conservation in the way in which sphingolipids are 
synthesized in animals, yeast and plants. These lipids can be formed via two pathways: 
the de novo pathway, starting with the condensation of a serine with an acyl-CoA, and the 
salvage pathway, where complex sphingolipids are catabolized followed by channeling of 
the metabolites formed into the synthetic pathway (Merrill, 2002; Hannun & Obeid, 
2008; Kitatani et al., 2008).   
The unique and defining structural feature of sphingolipids is an amino alcohol 
backbone called long-chain base (LCB) or sphingoid base. The simplest and most 
common LCB, sphinganine (d18:0), derives from the condensation of serine and 
palmitoyl-CoA catalyzed by serine palmitoyltransferase (SPT) and subsequent reduction 
of the 3-ketosphinganine product. LCBs can be further modified by hydroxylation, 
desaturation, and phosphorylation to yield a range of structural variants (Figure 1.1) 
(Markham et al., 2006; Chen, et al., 2009). In mammals, most sphingolipid structures 
contain sphingosine with Δ4 unsaturation (d18:1). In contrast, the most widely occurring 
LCBs in plants are sphinganine (d18:0), phytosphingosine (t18:0), 4-hydroxy-
∆8cis/trans-sphingenine (d18:1∆8trans/cis) and ∆4trans, ∆8cis/trans-sphingadiene 




Figure 1.1 Chemical structures of long chain bases (LCBs).  
Shown are examples of dihydroxy and trihydroxy LCBs commonly found in plants. Dihydroxy LCBs 
contain hydroxyl groups at C-1 and C-3 positions. Trihydroxy LCBs contain an additional hydroxyl group 
at C-4. Dihydroxy and trihidroxy LCBs can contain double bonds at ∆8 position in cis or trans 
configuration or in ∆4 position in trans configuration. The nomenclature d18:0 indicates that the LCB has 
two hydroxyl groups (d) and 18 carbons with no double bonds. 
 
Free LCBs and their phosphorylated forms typically occur in low concentrations 
in eukaryotic cells. In mammals, free LCBs account for less than 1% of the total 
sphingolipids in tissues (Alecu et al., 2017), however, they exert signaling functions such 
as modulating cell proliferation and apoptosis. In plant cells, free LCBs also serve as a 
trigger of programmed cell death (PCD) and are associated pathogen defense responses 
(Alden et al., 2011; Zheng et al., 2018; Huby et al., 2019). The majority of LCBs occur 
in ceramides and more complex glycosylated sphingolipids.  
The condensation of an LCB and a fatty acyl-CoA to form ceramides is catalyzed 
by ceramide synthases. Ceramide synthases have defined substrate specificities that result 
in ceramides with distinct pairings of structurally diverse LCBs and fatty acids (Markham 
et al., 2011; Ternes et al., 2011; Luttgeharm, et al., 2015a, Chen, et al., 2015). In yeast, 
the two ceramide synthases, Lag1p and Lac1p, have specificity for C26-acyl CoAs to 
form ceramide (Guillas et al., 2001). In contrast, six isoforms of ceramide synthases 
(CerS1-6) are expressed in mammals. Each isoform distinctly prefers to incorporate fatty 
acids of different chain lengths (C14-C32) into ceramides, this depends on the expression 
of the isoforms in certain cell type and environmental conditions (Levy and Futerman, 
4 
 
2010). In Arabidopsis thaliana (Arabidopsis), two classes of ceramide synthases have 
been identified. Class I, encoded by Longevity Assurance Gene One Homolog2 (LOH2), 
mostly uses C16-acyl-CoAs to form ceramides and class II, encoded by LOH1 and 
LOH3, act on acyl-CoAs containing more than 22 carbons (Ternes et al., 2011; 
Luttgeharm et al., 2015). 
Ceramides provide the hydrophobic backbone to generate a variety of more 
complex sphingolipids. In yeast, ceramides can be further modified to yield abundant 
species including inositolphosphorylceramides (IPCs) and the glycosylated 
derivatives: mannose inositolphosphoceramide (MIPC) and mannose-(inositol-P)2-
ceramide M(IP)2C (Dickson, 2010).  
In plants, glucosylceramides (GlcCer) and glycosylinositolphosphoceramides 
(GIPCs) are the most abundant sphingolipids (Gronnier et al., 2016; Markham et al., 
2006). GlcCer is the simplest glycosphingolipid that occurs broadly in eukaryotes, but not 
in Saccharomyces cerevisiae. GlcCer synthase is the ER-localized enzyme that catalyzes 
the condensation of ceramide with UDP-glucose (Leipelt et al., 2001). GlcCer are 
enriched with C16-ceramides and dihydroxy-LCBs (Markham et al., 2006). According to 
this composition, it has been suggested that the ceramide synthase Class I (LOH2) has 
preference for channeling the substrates to the formation of GlcCer. In contrast, GIPCs 
are enriched in ceramides with VLCFA and trihydroxy LCBs formed by the Class II 
ceramide synthases LOH1/LOH3 (Markham et al., 2006). Similarly, in the case of 
mammalian cells, ceramides are the precursors of GlcCer, galactosylceramides (GalCer) 




Figure 1.2 Sphingolipid biosynthesis in Arabidopsis. 
 Sphingolipid classes are indicated in green. Enzymes and the corresponding genes are indicated in blue. 
Solid arrows indicate biosynthesis steps and dashed arrows indicate catabolic steps.  Abbreviations: LCB, 
Long chain base; SPT, serine palmitoyltransferase; KSR, 3-ketosphinganine reductase; C4-OHase, C4-LCB 
hydroxylase; CSI, ceramide synthase class I; CSII, ceramide synthase class II; VLCFA, very long chain 
fatty acid, ∆8 Des, D8 desaturase; GCS, glucosylceramide synthase; GlcCerase, glucosylceramidase; IPCS, 
inositol phosphoceramide synthase; PI, phosphatidylinositol; DAG, diacylglycerol; CERK, ceramide 
kinase.   
 
sphingomyelin, characterized by the presence of a phosphorylcholine headgroup and 
gangliosides containing sialic acid residues.  
Sphingolipid synthesis is compartmentalized between two organelles in the cell. 
The synthesis of LCBs, ceramides and GlcCer takes place in the ER, but further metabolic 
steps to generate GIPCs occurs in the Golgi apparatus. As noted earlier, GlcCer contain 
higher amounts of C16 fatty acids and dihydroxy LCBs, instead, GIPCs are enriched in 
ceramides containing VLCFA and trihydroxy LCBs. In this scenario a selective vesicular 
or non-vesicular transport would be needed to for the synthesis of GIPCs in the Golgi 
apparatus. In mammals, ceramide is transported from the ER, the site of synthesis, to Golgi 
by a non-vesicular mechanism mediated by CERT proteins (Kudo et al., 2008).      
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Ceramides can also be deacylated by ceramidases to generate fatty acids and 
LCBs which may then be phosphorylated by LCB kinases to produce LCB-P. In 
mammalian cells, the sphingosine generated by ceramidases can be then phosphorylated 
by an LCB kinase generating sphingosine-1 phosphate (d18:1-P), a potent intra- and 
extra-cellular signaling molecule (Mao and Obeid, 2008). While ceramide synthases are 
the main route to synthesize ceramides, reverse ceramidase activity also contributes to 
ceramide formation (Mao et al., 2000). This ceramide synthase activity involves the 
condensation of a fatty acid and an LCB through an acyl-CoA-independent mechanism, 
this activity was first described in Saccharomyces cerevisiae for the ceramidases Ypc1 
and Ydc1 (Mao et al., 2000). Arabidopsis has one alkaline ceramidase (ACER) and three 
neutral ceramidases (NCER1,2,3) that are involved in keeping sphingolipid homeostasis 
under environmental stresses (Li et al., 2015; Wu et al., 2015; Zheng et al., 2018), 
however, the ceramide synthesis activity has yet to be determined for these enzymes.  
Finally, to exit the sphingolipid metabolic network, the phosphorylated forms of 
LCBs are substrate for LCB phosphate lyase also known as sphingosine-1-phosphate 
lyase (S1P-lyase or DPL1) the enzyme that catabolizes the sphingolipid backbone to 
produce ethanolamine phosphate and hexadecenal, both of which can enter the 
glycerolipid metabolism (Mao, Saba and Obeid, 1999; Tsegaye et al., 2007). 
 The pool of different sphingolipid species is in constant dynamic flux and 
responds to the metabolic demands on the cell and the biotic and abiotic stresses from the 
environment. This balance not only considers the de novo biosynthesis but also the 
breakdown of more complex sphingolipid species to give rise to intermediates of the 
pathway with a functional role. How cells sense alterations in sphingolipids levels, in 
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response to developmental cues or environmental stimulus, and adjust the rates of the 
reactions to maintain homeostasis are vital mechanisms which are only recently 
beginning to be understood.  
1.1.2 Serine Palmitoyltransferase  
The de novo sphingolipid biosynthetic pathway begins with SPT, a CoA-
dependent acyltransferase, which typically catalyzes the condensation of L-serine with 
palmitoyl coenzyme-A (palmitoyl-CoA) to form 3-ketosphinganine. Besides using L-
serine as substrate to form the canonical LCBs, SPT also shows activity towards glycine 
and L-alanine to generate an atypical category designated 1-deoxysphigolipids (Chapter 
4) (Penno et al., 2010).  The reaction catalyzed by SPT is highly conserved across 
multiple species even though the downstream enzymes have diverged in such a way to 
give rise to some sphingolipid species that are only found in mammals, plants or fungi.  
 In prokaryotes, SPT is a soluble homodimer with two catalytic sites at the 
interphase  (Hanada, 2003; Ikushiro et al., 2007; Yard et al., 2007). In eukaryotes, SPT 
consists of a heterodimer with two major subunits (LCB1 and LCB2 in yeast; LCB1 and 
LCB2a or LCB2b in plants; SPTLC1 and SPTLC2 or SPTLC3 in mammals). A third 
subunit is a small protein required for optimal activity. In yeast there is a single isoform 
(Tscp3), not required for basal activity but it can increase it by 30 fold. In higher 
eukaryotes there are more subunits, in plants (ssSPTa and ssSPTb) or three in the case of 
mammals (Kimberlin et al., 2013; Han et al., 2009). These subunits confer acyl-CoA 
specificity and can increase the activity by 100 fold.  
In mammalian cells, the subunit composition of SPT determines fatty-acyl-CoA 
substrates. For example, the complex formed by SPTCL3 and/or ssSPTb allow the use of 
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other shorter or longer acyl-CoAs to generate atypical LCBs (Han et al., 2009). While 
palmitoyl-CoA is the preferred substrate for the complex SPTLC1/2 ssSPTa, other 
combinations with SPTLC3 ssSPTb can use myristoyl (14:0)-CoA and stearoyl (18:0)-
CoA.  
Interestingly, in Arabidopsis, it is only 33 amino acids of ssSPTa which are 
required for activation of the SPT heterodimer and for conferring the acyl-CoA 
specificity (Kimberlin et al., 2013). A single mutation in ssSPTa (Met25 to Gly) results 
in the change of substrate specificity from C16 acyl-CoA to longer substrates (C20). 
However, the exact molecular details of how these small proteins stimulate SPT activity 
are still unknown and what is the functional effect of the generation of atypical 
sphingolipids is also under investigation.  
1.1.3 Regulatory Mechanisms of SPT Activity  
Sphingolipid metabolism can be regulated at multiple levels, including enzyme 
expression, degradation and localization, post-translational modifications, protein-protein 
interactions and allosteric mechanisms. These regulatory mechanisms respond to 
intracellular sphingolipid levels and to extracellular stimuli. SPT, as the first enzyme of 
the pathway, controls the amounts of serine and palmitoyl-CoA that get channeled for 
sphingolipid biosynthesis, therefore this step is tightly regulated. The molecular 
mechanisms of governing the regulation of SPT are complex and constitute an active area 
of research. 
The formation of higher order oligomers has been proposed as a mechanism for 
regulating SPT activity. In the case of the mammalian SPT, it has been shown that the 
functional complex is an octamer of catalytic heterodimers with a molecular mass of 
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~480 kDa. This highly organized complex includes the three SPT subunits (SPTLC1, 
SPTLC2 and SPTLC3) with a stoichiometry that is in dynamic change (Hornemann, Wei 
and Von Eckardstein, 2007). In addition to oligomerization of the SPT complex, changes 
in subcellular localization might also be related to the regulation of its activity. Based on 
localization studies, the repressed SPT resides to the peripheral ER and the active form in 
the perinuclear (Breslow et al., 2010).  
1.1.4 ORM Proteins are Regulators of SPT activity 
Additional members of the SPT complex are the Orosomucoid or ORM proteins. 
There are two isoforms of ORM proteins in yeast (Orm1 and Orm2) and plants (ORM1 
and ORM2) and three isoforms of ORMDLs in mammalian cells. These non-catalytic 
proteins play a role as negative regulators of SPT activity. 
The first evidence of the role of Orm proteins in the regulation of sphingolipid 
synthesis revealed that the deletion of Orm1/2 resulted in an increase of sphingolipid 
levels compared to wild type cells in yeast (Breslow et al., 2010). Interestingly, the 
Δorm1Δorm2 mutant was more sensitive to DTT and tunicamycin, compounds known to 
induce unfolded protein response (UPR) and ER stress (Han et al., 2010). Similar results 
were obtained using mammalian cells, where downregulation of the three ORMDL 
isoforms by siRNAs led to 3-fold increase in ceramide levels (Breslow et al., 2010). 
In Saccharomyces cerevisiae, SPT activity is regulated by Orms through post-
transcriptional mechanisms in response to sphingolipids availability. This was established 
when the inhibition of SPT using myriocin triggered the phosphorylation of Orm proteins 
and caused a change in their subcellular localization from cortical to perinuclear ER 
(Breslow et al., 2010). When sphingolipid levels are reduced, by decreasing SPT activity, 
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Orm proteins get phosphorylated at N-terminal serine residues by the Ypk1 kinase, 
downstream of TORC2, releasing SPT from Orm inhibition (Roelants et al., 2011; Sun et 
al., 2012). Once sphingolipids have been replenished the ceramide responsive 
phosphatase (PP2A) (Sun et al., 2012) dephosphorylates Orms allowing the regulatory 
inhibition of SPT. A current model of sphingolipid synthesis regulation in yeast suggests 
the formation of  higher-order oligomers including Orms and the SPT subunits Lcb1/2 
that respond to specific requirements of sphingolipids by modulating SPT activity 
(Breslow et al., 2010). 
In addition, another layer of regulation is attributed to the phosphorylation at 
different serine residues by the kinase NPR1, downstream of TORC1, in response to 
limiting complex sphingolipids. In this case, the mechanisms activate complex 
sphingolipids synthesis and migration to the plasma membrane where they exert an effect 
on the permease to allow the internalization of nutrients (Shimobayashi et al., 2013).   
While multiple evidences show that plant and mammalian ORM proteins play a 
key role in regulating SPT activity, it is clear that the regulatory mechanisms differ from 
those in yeast due to the lack of the phosphorylation sites at the N-terminus of the plant 
ORM protein. In this context, recent studies using mammalian cell cultures suggested that 
the regulation of SPT by ORMDLs does not require cytosolic proteins or small molecules 
like ATP, ruling out the possibility of post-translational modifications like phosphorylation 
as a regulatory process (Davis et al., 2019). Instead, the ORM-SPT regulation seems to 
respond to ceramide levels. Gupta et al. (2015) described how the induction of SPT activity 
increased ORMDL protein levels and blocking ceramide synthases suppressed this 
regulation. Additionally, incubation of isolated membranes with soluble ceramides 
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strongly inhibited de novo sphingolipid biosynthesis (Davis et al., 2019). These results 
indicate that ORMDL proteins might be regulated by an allosteric effect of ceramide or by 
a ceramide sensitive protein-protein interaction involving ORMs. However, although some 
evidences point to ceramides containing trihydroxy LCBs and VLCFAs as the main 
candidates to orchestrate this regulation, the mechanism is still unclear (Davis et al., 2019). 
Moreover, another open question is whether each ORMDL isoform is responding to 
ceramide levels and regulating SPT in the same way.  
1.1.5 Localization and Topology of ORM proteins 
ORMs are primarily localized to the ER (Kimberlin et al., 2016). However, recent 
reports in plants showed ORMs can also localize in vesicles and in the PM to exert other 
functions related to protein degradation by autophagy playing a key role in plant 
immunity (Yang et al., 2019).  
The ORM proteins form stable complexes with SPT subunits to regulate its 
activity, direct binding of Orm1 and Orm2 with Lcb1, Lcb2, and Tsc3 has been reported 
in yeast, however the key regions involved in these interactions are not known. Different 
biochemical approaches have been used to determine the topology of ORM proteins with 
the final goal to predict regions involved in protein-protein interaction and to identify the 
allosteric ceramide binding domain.  The topology of mammalian ORMDL3 and 
ORMDL1 proteins was determined using fluorescence-based protease protection assay 
and substituted cysteine accessibility method (SCAM), respectively (Davis, Suemitsu and 
Wattenberg, 2019). While the topology of the yeast Orm2 and the Arabidopsis ORM1 
protein was studied using inserting glycosylation cassettes at specific sites of the protein 
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(Kimberlin et al., 2016). These different approaches confirmed the existence of four 
transmembrane domains with the amino- and carboxy- termini facing the cytosol. 
1.1.6 Degradation of ORM proteins  
An additional mechanism for the regulation of SPT activity is the increased 
turnover of ORM proteins. In mammalian cells, the imbalance of PM lipid composition 
generated by adding exogenous cholesterol induced degradation of ORMDL1 protein, 
through autophagy, and resulted in increased SPT activity without changes in the levels of 
SPT subunits (Wang et al., 2015).  In yeast, a selective degradation of Orm2 by a novel 
route was shown to contribute to sphingolipid homeostasis. The phosphorylation of Orm2 
via the TORC2-dependent Ypk1 kinase triggers its export from the ER to the Golgi. Once 
on Golgi and endosomes, Orm2 is poly-ubiquitinated by the ubiquitin ligase complex 
(Dsc). Then Cdc48/VCP extracts ubiquitinated Orm2 from membranes for proteasomal 
degradation (Schmidt et al., 2019). This novel degradation pathway by EGAD (endosome 
and Golgi-associated degradation pathway) prevents the accumulation of Orm2 at the ER 
and promotes the controlled de-repression of sphingolipid biosynthesis. Interestingly, 
although Orm1 shares 72% amino acid identity with Orm2, this protein was not target of 
the Dsc complex for degradation. 
Regulation of sphingolipids biosynthesis is crucial for growth and to respond to 
environmental stimuli. Several exciting discoveries have been made in this area of research 
in the last decade, however, many questions remain unanswered. For example, the 
mechanisms behind the SPT regulation by ORM proteins in multicellular eukaryotes 
remain unclear. While in the yeast model the post-translational modifications are essential 
for sensing and responding to sphingolipid availability, in plants and mammals the 
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allosteric regulation and protein-protein interactions appear to be the governing 
mechanisms. Although the yeast Orm double knockout has been characterized, the lack of 
a complete knockout in plants limits the study of the physiological implications of an 
unregulated sphingolipid biosynthesis in multicellular eukaryotes. In Chapter 2 of this 
thesis we show ORM1 and ORM2 are essential for life cycle completion in Arabidopsis.  
orm1−/− orm2−/− seeds were nonviable, accumulated ceramide levels, displayed aberrant 
embryo development, and had >80% reduced oil content versus wild-type seeds. This 
phenotype was mimicked in Arabidopsis seeds expressing the SPT subunit LCB1 lacking 
its first transmembrane domain, which is critical for ORM-mediated regulation of SPT. In 
Chapter 3, we provide some insights about the regulatory interaction of ORM proteins with 
the LCB1 subunit of SPT. This was possible by the characterization of the orm1∆met/∆met 
orm2−/− mutant, which expresses an ORM1 structural variant that is strongly compromised 
in the regulation of SPT activity. These plants that did not advance beyond the seedling 
stage and hyperaccumulated ceramides and other sphingolipids.  
In addition, despite the compelling evidence of the functional redundancy of ORM 
isoforms in yeast, mammals and plants; recent reports point to potential individual roles 
and distinct regulation of each ORM isoform (Dang et al., 2017; Schmidt et al., 2019). In 
Chapter 2 we also uncovered phenotypical growth differences of orm1+/− orm2−/− and 
orm1−/− orm2+/− mutants that provide insights into potential differential roles of ORM1 and 
ORM2 in plant development. This area of study remains unexplored in the context of 
sphingolipid biosynthesis and other physiological processes.  
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1.2 Deoxysphingolipids  
Sphingolipid metabolism has been extensively studied in humans due to the 
association of mutations in genes encoding enzymes of the sphingolipid pathway to 
diseases (Hannun and Obeid, 2018; Dunn et al., 2019). One example is the rare condition 
Hereditary Sensory and Autonomic Neuropathy type 1 (HSAN1) that has been associated 
the production of  deoxysphingolipids (Penno et al., 2010). Deoxysphingolipids are 
atypical sphingolipids that are generated when SPT utilizes alanine or glycine instead of 
serine. As mentioned before, in the sphingolipid biosynthesis pathway, the formation of 
the canonical LCB sphinganine (d18:0) requires the condensation of palmitoyl-CoA with 
L-serine. Instead, the use of L-alanine gives rise to 1-deoxysphinganine (1-deoxySA; 
m18:0) and glycine results in the formation of 1-deoxymethylsphinganine (1-
deoxymethylSA; m17:0) (Lone et al., 2019) (Figure 1.3).  
 
Figure 1.3 Chemical structures of deoxyLCBs. 
Shown are the LCB sphinganine (d18:0) and the deoxyLCBs 1-deoxysphinganine (1-deoxySA; m18:0) and 
1-deoxymethylsphinganine (1-deoxymethylSA; m17:0). The position of double bonds in plant deoxyLCBs 
is not known.    
These LCBs, and the compounds derived from them, are called 1-
deoxysphingolipids due to the lack of the hydroxyl group at C1 position which prevents 
the addition of a polar head group to the ceramide backbone to generate more complex 
sphingolipids which are the major forms in which LCBs occur in the cell. In addition, it is 
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important to note that the lack of the 1-hydroxyl group in these compounds precludes 
their canonical catabolism through the generation of LCB-1-phosphates.  
In the last decade, great progress has been made understanding the metabolism 
and effects of deoxysphingolipids in the context of the HSAN1 condition in humans. 
However, even though these lipids have been also found in fungal species and marine 
organisms such as Spisula polynyma (Cuadros et al., 2000),  they remain largely 
unexplored in plants. In this section we present some of the advances understanding the 
synthesis and cellular effects of deoxysphingolipids in mammalian cells and yeast.   
1.2.1 HSAN1 Mutations are Related to the Synthesis of Deoxysphingolipids  
Even though wild-type SPT can generate deoxyLCBs, missense mutations in the SPTLC1 
and SPTLC2 subunits have been linked to increased levels of deoxysphingolipids in the 
context of HSAN1 (Penno et al., 2010; Zitomer et al., 2009). Some of the most frequent 
mutations found in patients are SPTLC1 C133W, C133Y, S331F, S331F and SPTLC2 
A182P, G382V, S384F, I504F (Bode et al., 2015); the analysis of  structural models 
suggests these mutations induce a shift in the substrate specificity of SPT, from L-serine 
to L-alanine or glycine which leads to the formation of the two 1-deoxyLCBs (Penno et 
al., 2010; Bode et al., 2015). In contrast, other mutations localized to the surface of the 
protein (SPTLC1-S331Y and SPTLC2-I505F) are associated with a severe HSAN1 
phenotype and could be involved in protein-protein interactions favoring the production 
of these atypical sphingolipids (Rotthier et al., 2010). 
For ceramide formation, the N-acylation of LCBs and fatty acyl-CoAs of different 
chain length is defined by the ceramide synthase substrate preference. There is also a 
distinction in the N-acyl chain distribution of deoxyceramides. In mouse fibroblasts, 
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supplementation with m18:0 revealed this LCB was incorporated to a variety of acyl-
CoAs from C16 to C24:1; while m18:1 was preferentially acylated to VLCFA (Alecu et 
al., 2017). However, in contrast to the typical ceramides where the ∆4-desaturase 
(DEGS1) introduces a trans double bond at ∆4 position, in the deoxyceramides the 
double bond is at position ∆14, and the desaturase has not been identified (Steiner et al., 
2016).  
 
Figure 1.4 Chemical structures of ceramides. 
Ceramides are formed by the condensation of a LCB and a fatty acyl-CoA through ceramide synthase. (A) 
Hydroxyceramide composed of the LCB t18:1 ∆8 trans and the fatty acid 24:1ω9cis hydroxylated at C-2 
position. (B) Non-hydroxylated deoxyceramide composed of the LCB m18:0 and the fatty acid 16:0.    
 
1.3 Cellular Effects of Deoxysphingolipids  
Even though the underlying mechanisms behind the HSAN1 condition are not 
fully understood, the toxic effects on the neurons and other cells have been attributed to 
the accumulation of deoxysphingolipids. Some of the effects include altered Ca2+ levels 
related to changes in mitochondria and ER morphology (Alecu et al., 2017); disassembly 
of actin fibers and other changes in cytoskeletal structures and (Cuadros et al., 2000), 
changes in the physicochemical properties of membranes (Jiménez-Rojo et al., 2014).  
In mammalian cells, the accumulation of canonical ceramides, either by de novo 
synthesis or hydrolysis of complex sphingolipids, activates apoptosis (Bartke and 
Hannun, 2009). In addition to the activation of signaling pathways, another way the 
accumulation of ceramides may impact cell processes is by alterations in the biophysical 
properties of membranes. Saturated ceramides increase the order of the fluid membranes 
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and tend to form gel domains; while ceramides with VLCFA promote the formation of 
interdigitated phases (Pinto et al., 2011). In contrast to canonical sphingolipids, the lack 
of the hydroxyl group in position 1 make deoxyceramides more hydrophobic and limits 
their capacity to form hydrogen bonds with other membrane lipids. This results in poor 
miscibility with other membrane lipids, aggregation and a great influence in cellular 
membranes, especially the ER membrane in which these lipids are synthesized. Studies 
on giant unilamellar vesicles (GUVs) made with a mixture of sphingomyelin and 
deoxyceramides revealed that these lipids induce gel-fluid phase separation and are able 
to induce the vesiculation of these GUVs (Jimenez-Rojo et al., 2014). It is important to 
note that the impact on membrane integrity is also dependent on the abundance of these 
compounds. Interestingly, Jimenez-Rojo et al. (2014) found comparable amounts of 1-
deoxyDHCers and ceramides in a murine macrophage cell line under normal conditions.  
1.3.1 HSAN1-like Mutations Affect SPT Activity  
Analysis of HSAN1 patients revealed the two most frequent mutations correspond 
to SPTLC1 at Cys133 (C133W or C133Y) and Val144 (V144D), these residues are in a 
highly conserved region of LCB1 that is predicted to be a catalytic domain. Gable et al. 
(2001) found that the corresponding mutations (C180W, C180Y, and V191D) in the 
LCB1 gene of Saccharomyces cerevisiae reduced SPT activity by 50 % and increased the 
levels of 1-deoxySA. Similarly, HSAN1-associated mutations were shown to confer 
dominant negative effects on the SPT activity in lymphoblasts even though the protein 
levels of LCB1 and LCB2 subunits did not change (Bejaoui et al., 2002). Reduced SPT 
activity was also observed in transgenic mice expressing the LCB1C133W allele 
(McCampbell et al., 2005), however, even though the composition of the ceramide pool 
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was altered, the total ceramide levels in these mice were unaffected. This suggests the 
activation of alternative mechanism to regulate ceramide degradation or the conversion to 
glycosylated sphingolipids. Interestingly, using a metabolic labeling approach the 
mutations in SPTLC1S331F/Y and SPTLC2I504F resulted in increased SPT activity when 
expressed in HEK293 cells, and the rest of the seventeenth analyzed mutations did not 
induce any change in activity. However, under FB1 treatment eleven mutations induced a 
reduction in SPT activity (Bode et al., 2015). 
1.3.2 Degradation of Deoxysphingolipids  
1-deoxyspingolipids lack the hydroxyl group at C1 which prevents the addition of 
a polar head group to the ceramide backbone to generate more complex sphingolipids. In 
addition, the lack of this hydroxyl group also blocks the phosphorylation of LCBs 
affecting the canonical degradation pathway by the enzyme LCB lyase that uses 
phosphorylated LCBs to generate phosphoethanolamine and hexadecenal, the breakdown 
products of sphingolipid catabolism.  
The accumulation of 1-deoxysphingolipids has been used a strategy in yeast to 
indirectly measure the activity of SPT under the assumption that these structures 
accumulate and are not degraded. However, a recent report showed the reduction of 
intracellular concentration of 1-deoxysphingolipids over time suggesting alternative 
degradation/elimination pathways. 1-deoxysphingosine (m18:1) was metabolized to a 
variety of hydroxylated downstream metabolites that appeared to be formed by 
cytochrome P450 enzymes (Alecu et al., 2017). Compared to the catabolism of the 
canonical LCBs that takes place in minutes to hours, the conversion of the newly 
identified metabolites is slower and can take up to several days (Alecu et al., 2017).  
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In Chapter 4, we describe that the incorporation of HSNA1-like mutations into 
Arabidopsis resulted in early senescence and resistance to the cell death triggered by the 
mycotoxin Fumonisin B1.  
1.4 Metabolic Modeling  
Computational systems biology has emerged as a field to describe biological 
networks using mathematical models. Mathematical modeling allows to describe the 
behavior of complex biological systems characterized by a substantial larger number of 
parameters  for predicting cellular phenotypes (Kim, Rocha and Maia, 2018). Some 
applications include the design of microbial strains for overproduction of metabolites of 
industrial interest. The process of model building is iterative, combining experimental 
testing for validation and in silico analysis for optimization (Gadkar, Gunawan and 
Doyle, 2005). A model can accelerate the process of hypothesis generation and testing by 
predicting plausible regulatory mechanisms that satisfy the observed experimental 
behavior of the system under different growth conditions. It can also allow the simulation 
of acute perturbations that are normally not amenable to try with experimentation. 
 Depending on the specific applications, mathematical models vary in their 
formulation and complexity. The two main categories of mathematical modeling applied 
to metabolism are: steady state and kinetic (Islam and Saha, 2018).   
Flux balance analysis (FBA) is in the category of steady-state modeling and relies 
on genome-scale metabolic models and the stoichiometry of the metabolic networks to 
predict the optimal flux distribution and the impact of perturbations (e.g. gene knock-
out/overexpression) (Varma and Palsson, 1994). This approach allows the quantitative 
interpretation of the metabolic physiology to provide a method for the design and 
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optimization of bioprocesses. However, steady-state/stoichiometric models do not capture 
essential information like metabolite concentration, enzyme kinetics and regulatory 
processes.    
Meanwhile, the use of dynamic models including metabolic and regulatory 
processes through kinetic expressions (rate equations of enzyme reactions), increases the 
accuracy of the phenotype predictions in terms of the temporal behavior of the metabolic 
network (Zielinski and Rohwer, 2012). However, practical applications of this approach 
are often not feasible due to the lack of defined enzyme kinetic parameters for all 
enzymes in the network.  
To overcome this limitation, ensemble kinetic modeling (EM) (Tran, Rizk and 
Liao, 2008) was developed to build accurate predictive models by sampling through the 
entire allowable kinetic solution space. A strategy to reduce the allowable solution space 
that needs to be spanned is enforcing thermodynamic feasibility constraints on the 
metabolic reactions (Henry, Broadbelt and Hatzimanikatis, 2007; Tran, Rizk and Liao, 
2008). The model is then filtered using measured parameters of the system’s response to 
different genetic perturbations (Rizk and Liao, 2009). In addition, EM can be used to 
predict regulatory interactions occurring in biochemical pathways (Khazaei, McGuigan 
and Mahadevan, 2012).  
Most of the metabolic modeling for biotechnological purposes has been done in 
prokaryotes. Some reasons for the scarcity of eukaryotic models are derived from the 
complexity of these organisms in terms of subcellular localization of 
proteins/metabolites, intra and extra cellular transporters, limited knowledge of gene 
annotation, interactions with different tissues/organs. 
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1.4.1 Modeling Sphingolipid Metabolism  
Currently, only few models of sphingolipid metabolism are available in the 
literature. In part, this is due to the challenges given by the diversity in sphingolipid 
composition and the complexity of the numerous interconnected reactions that happen in 
various subcellular compartments. A mathematic model of the sphingolipid biosynthesis 
was first reported in yeast. This model allowed simulations of metabolic fluxes, included 
the connection with phospholipid metabolism and was able to predict outcomes when 
enzyme where deleted (Alvarez-Vasquez et al., 2005). A second study in yeast developed 
a comprehensive kinetic model which can predict changes in enzyme activity based on 
changes in metabolic concentrations that result from genetic perturbations. This model 
included pathways for the synthesis of fatty acids to determine potential genes that 
impact the distribution of sphingolipid species (Savoglidis et al., 2016). Beyond yeast, 
(Gupta et al., 2011) proposed a model including data from lipidomic and transcriptomic 
analyses to describe the sphingolipid pathway in mammalian cells. In addition, a recent 
study described a model of sphingolipid metabolism in human tissue that simulates the 
molecular scenarios in the context of Alzheimer disease including different subcellular 
compartments (Wronowska et al., 2015).  
It is important to note how various regulatory processes, at the transcriptional and 
protein levels are important for the homeostasis of the sphingolipid synthesis.  The 
previously reported sphingolipid models did not consider regulatory parameters in the 
kinetic models or assumed a defined regulatory network. The inclusion of the regulation 
schemes by ORMs and other proteins in the models can have an impact on the analysis of 
the network response and thus can lead to different conclusions and hypotheses.  
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Previous efforts on modeling the sphingolipid pathway have used Saccharomyces 
cerevisiae and mammalian cells, however, there are no models based on data from plant 
sphingolipid metabolism. It is important to note that the sphingolipid levels typically 
reported in the literature correspond to steady state measurements, the result of the 
synthesis and turnover of metabolites that cannot be distinguished with the analytical 
tools. In Chapter 5, we provide some advances towards building a sphingolipid kinetic 
model with measurements derived from metabolic labeling. It is then intent of such 
model to provide a basis for understanding synthesis and turnover of sphingolipids in the 
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2 Chapter 2 Unregulated Sphingolipid Biosynthesis in Gene-Edited Arabidopsis 
ORM Mutants Results in Nonviable Seeds. 
The content of this chapter has been published.  
Ariadna Gonzalez-Solis, Gongshe Han, Lu Gan, Yunfeng Li, Jonathan 
E. Markham, Rebecca E. Cahoon, Teresa M. Dunn, Edgar B. Cahoon. Unregulated 
Sphingolipid Biosynthesis in Gene-Edited Arabidopsis ORM Mutants Results in 
Nonviable Seeds with Strongly Reduced Oil Content. The Plant Cell Aug 
2020, 32 (8) 2474-2490; DOI: 10.1105/tpc.20.00015. 
2.1 Abstract 
Orosomucoid-like proteins (ORMs) interact with serine palmitoyltransferase (SPT) to 
negatively regulate sphingolipid biosynthesis, a reversible process critical for balancing 
the intracellular sphingolipid levels needed for growth and programmed cell death. Here, 
we show that ORM1 and ORM2 are essential for life cycle completion in Arabidopsis 
(Arabidopsis thaliana). Seeds from orm1−/− orm2−/− mutants, generated by crossing 
CRISPR/Cas9 knockout mutants for each gene, accumulated high levels of ceramides, 
indicative of unregulated sphingolipid biosynthesis. orm1−/− orm2−/− seeds were nonviable, 
displayed aberrant embryo development, and had >80% reduced oil content versus wild-
type seeds. This phenotype was mimicked in Arabidopsis seeds expressing the SPT 
subunit LCB1 lacking its first transmembrane domain, which is critical for ORM-
mediated regulation of SPT. In this study we also uncovered phenotypical growth 
differences of orm1+/− orm2−/− and orm1−/− orm2+/− mutants that provide insights into 
potential different roles of ORM1 and ORM2 in plant development.  
2.2  Introduction 
Sphingolipids are essential and abundant endomembrane and plasma membrane 
lipids that contribute to membrane function, vesicular trafficking, and mediation of 
cellular processes in eukaryotes (Coursol et al., 2003; Liang et al., 2003; Chen et al., 
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2006; Markham et al., 2011).  Serine palmitoyltransferase (SPT), the first step in 
sphingolipid biosynthesis, is highly regulated in eukaryotes to modulate the requirement 
of sphingolipids for growth and membrane function, while limiting accumulation of 
LCBs and ceramides until needed to trigger specific cellular functions, such as PCD-
mediated pathogen defense in plants (Peer et al., 2010).  SPT is comprised of LCB1 and 
LCB2 subunits and the accessory protein known as small subunit of SPT (ssSPT) or 
TSC3 in Saccharomyces cerevisiae (S. cerevisiae) (Gable et al., 2000; Kimberlin et al., 
2013). SPT is primarily regulated by post-translational mechanisms in order to rapidly 
respond to perturbations in intracellular sphingolipid concentrations. ORMs or 
orosomucoid-like proteins (or ORMDL in mammals) are now recognized as non-catalytic 
proteins that negatively regulate SPT (Breslow et al., 2010; Han et al., 2010). In S. 
cerevisiae, Orm1p and Orm2p suppress SPT activity in response to elevated sphingolipid 
levels through physical interaction that requires the first transmembrane domain of LCB1 
(Han et al., 2019). Sphingolipid-responsive regulation of the ORM-SPT interaction in S. 
cerevisiae is mediated by phosphorylation/dephosphorylation of the N-terminal domain 
of the ORMs (Breslow et al., 2010).  This domain is absent from ORM/ORMDL of 
higher eukaryotes suggesting alternative regulation of the ORM-SPT interaction, such as 
a recently demonstrated mechanism of direct binding of a ceramide molecule to 
mammalian ORMDL and yeast ORM to confer negative SPT regulation (Davis et al., 
2019). In addition, ORMDL expression levels vary with sphingolipid availability in 
mammalian cells (Gupta et al., 2015). 
S. cerevisiae cells are viable after knockout of the two ORM genes, but 
accumulate increased amounts of LCBs and ceramides and are sensitive to tunicamycin, 
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an inducer of ER stress (Breslow et al., 2010).  However, to date, a full understanding of 
the biochemical and physiological functions of ORM or ORMDL porteins in multi-
cellular eukaryotes is only beginning to emerge. A recent report showed that ORMDL 
proteins are critical for nerve myelination and for suppressing accumulation of toxic 
sphingolipid biosynthetic intermediates in mice (Clarke et al., 2019).  Studies in 
Arabidopsis have previously shown that downregulation of ORM2 using an artificial 
miRNA in an ORM1 T-DNA mutant yields fertile plants with increased accumulation of 
LCBs and ceramides and early senescence (Li et al., 2016). In addition, RNAi 
suppression of Arabidopsis ORM1 and ORM2 resulted in plants with normal appearance 
but with increased sensitivity to the ceramide synthase inhibitor fumonisin B1 and 
increased LOH2 ceramide synthase activity (Kimberlin et al., 2016).  Beyond 
Arabidopsis, RNAi of ORM genes in rice was linked to reduced pollen viability 
(Chueasiri et al., 2014).  
The lack of complete ORM knockout mutants in Arabidopsis or other plants has 
precluded assessment of SPT regulation in the absence of ORM proteins. To advance our 
understanding of ORM-mediation of sphingolipid biosynthesis we generated 
ORM1/ORM2 double mutants using CRISPR/Cas9. Our findings show that in full 
ORM1/ORM2 knockout mutants removing sphingolipid biosynthesis regulation results in 
nonviable seeds with impaired embryo development, ceramide accumulation and strongly 
reduced oil content. We obtained the same phenotypes by removing the first 
transmembrane domain of the LCB1 subunit of SPT which is known to be essential for 
ORM-SPT interaction.    
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2.3 Materials and Methods 
2.3.1 Plant Materials and Growth Conditions 
 Arabidopsis (Arabidopsis thaliana) Columbia-0 (Col-0) was used as the wild-type 
reference in this study. Arabidopsis seedlings were grown on Murashige and Skoog (MS) 
medium supplemented with 1% (w/v) Sucrose and 0.8% (w/v) agar, pH 5.7, with 16-h-
light (100 mmol/ m-2 s-1)/8-h-dark conditions at 22°C. The light source for growth 
chamber–grown seedlings was supplied by standard wide-spectrum fluorescent bulbs 
type F32/841/ ECO 32 W (maximum intensity, 480 to 570 nm). For Arabidopsis plants in 
soil, seeds were sown, and after 2 d of stratification at 4°C, plants were grown at 22°C 
with 16-h-light (100 mmol/ m-2 s-1)/8-h-dark conditions.  
2.3.2  Generation of CRISPR/Cas9 ORM Mutants 
 For CRISPR/Cas9-mediated gene editing of ORM1 and ORM2, designed target sites 
(Figure 2.1A) were fused with a single guide RNA and expressed under the control of the 
U6 promoter. The egg cell–specific EC1 promoter was used to drive Cas9 expression as 
previously reported by Wang et al. (2015). In short, BsaI sites were incorporated by PCR 
into the ORM target sequences (primers P1 to P4; Supplemental Table 1 in Appendix A). 
The purified PCR products were digested with BsaI and ligated to the BsaI-linearized 
binary vector pHEE401E. The final CRISPR/Cas9 binary vector was electroporated into 
Agrobacterium tumefaciens strain GV3101 and then transformed into the Arabidopsis 
Col-0 wild-type plants via the floral dip method (Clough and Bent, 1998). The seeds were 
screened for hygromycin resistance on MS plates containing 25 mg/L hygromycin. For 
genotyping, fragments including the target regions of ORM1 and ORM2 were amplified 
by PCR from the genomic DNA of transgenic plants (primers P5 to P8; Supplemental 
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Table 1 in Appendix A). Amplicons were digested with the restriction enzymes BslI 
(ORM1) and DraIII (ORM2). The specific indels were identified by DNA sequencing. To 
analyze for nontransgenic plants, progeny of hygromycin-selected and confirmed 
homozygous (CRISPR/Cas9 mutation) T1 plants were sown directly on soil without 
hygromycin selection. These plants were then screened by PCR (P9+P10; Supplemental 
Table 1 in Appendix A) for the lack of the Cas9 gene with the presence of the CRISPR 
mutation, in the T2 generation. The plants lacking Cas9 but containing the CRISPR 
mutation were kept and used for further studies as mutated but not transgenic lines.  
2.3.3  Generation of the LCB1∆TMD1 Mutant 
LCB1∆TMD1 was generated by deleting coding sequence for 17 amino acids 
corresponding to the first transmembrane domain of AtLCB1 (amino acids 35 to 51). 
LCB1∆TMD1 under the control of the LCB1 native promoter was cloned into the 
pBinGlyRed3 binary vector, which was transformed into A. tumefaciens GV3101 by 
electroporation. Heterozygous LCB1/lcb1- knockout mutants (SALK_077745) were 
transformed by the floral dip method (Clough and Bent, 1998).  
2.3.4 Pollen Staining  
Anthers of mature plants were isolated and smeared on a glass slide. The pollen was 
stained using Alexander staining method (Alexander, 1969) for 1 h at 25°C. Pollen 
imaging was performed using the EVOS FL Auto Cell Imaging System. 
2.3.5 Sphingolipid Extraction and Analysis  
Sphingolipids were extracted as described in Markham and Jaworski (2007). Briefly, 
leaves from 20- to 30-d-old Arabidopsis plants grown on soil were collected and 
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lyophilized.  Ten to 30 mg of tissue was homogenized and extracted with 
isopropanol:heptane:water (55:20:25, v/v/v). We used 1 to 4 mg of plant material for 
each biological replicate for sphingolipid analysis from seeds. Internal standards for the 
different sphingolipid classes were added. The supernatants were dried and deesterified 
with methylamine in ethanol:water (70:30, v/v). The lipid extract was re-suspended in 
tetrahydrofuran:methanol:water (5:2:5, v/v/v) containing 0.1% (v/v) formic acid. The 
sphingolipid species were analyzed using a Shimadzu Prominence ultra-performance 
liquid chromatography system and a 4000 QTRAP mass spectrometer (AB SCIEX). Data 
analysis and quantification were performed using the software Analyst 1.5 and 
MultiQuant 2.1 as described by Markham and Jaworski (2007), Kimberlin et al. (2013), 
and Davis et al. (2020). 
2.3.6 Lipid Extraction Analysis 
To quantify the TAG content, lipids were extracted from ~1 mg of seeds using a method 
based on that of Bligh and Dyer (1959). Seeds were ground using a glass rod in 13x100-
mm glass screw cap tubes with 3 mL of methanol:chloroform (2:1, v/v). 
Triheptadecanoin (17:0-TAG) was added to the seeds as an internal standard prior to 
extraction. After 1 h of incubation at 25°C, 1 mL of chloroform and 1.9 mL of water were 
added. The solution was mixed thoroughly and centrifuged at 400g for 10 min. The lower 
organic phase containing total lipids was transferred to a new glass tube and solvent 
evaporated under a N2 stream with heating at 40°C. The sample was redissolved in 1 mL 
of heptane and loaded onto a solid phase extraction column (Supelco Supelclean LC-Si 
SPE column; Sigma-Aldrich) pre-equilibrated with heptane. A purified TAG fraction was 
eluted from the column and converted to fatty acid methyl esters, which were analyzed 
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by gas chromatography as previously described (Zhu et al., 2016). TAG fatty acid content 
was quantified relative to 17:0 fatty acid methyl ester from the internal standard. 
2.3.7 Statistical Analyses 
Two-tailed Student’s t test was performed to evaluate statistically significant differences 
compared to the control (wild type). One-way ANOVA followed by Tukey’s test was 
used to determine the differences among the five genotypes for a given variable. Values 
of P < 0.05 were considered statistically significant. The statistical analyses were done 
using GraphPad Prism 8.3.0.  
2.4 Results 
2.4.1 ORMs Are Essential for Plant Development  
We designed two single guide RNAs to target regions in the coding sequence of each of 
the two Arabidopsis ORM genes (Figure 2.1A). We introduced these constructs into 
Arabidopsis via Agrobacterium tumefaciens–mediated transformation to generate 
CRISPR/Cas9-induced knockouts of the ORM1 and ORM2 genes. We screened T1 and 
T2 transformants by restriction enzyme digestion of the PCR amplicons encompassing 
the ORM1 and ORM2 target sites to obtain homozygous lines with mutations in each 
gene. These lines were also verified by PCR to lack Cas9 transgenes. These homozygous 
single mutants were visually indistinguishable from wild-type plants under optimal 




Figure 2.1 Gene-edited ORM Arabidopsis mutants. 
(A) Schematic representation of CRISPR/Cas9-induced mutations in ORM genes. Gene structures of ORM1 
and ORM2; black boxes represent exons. The CRISPR/Cas9 target site is indicated as well as the nucleotide 
deletions for each gene in the single mutants. (B) Representative images of 25-d-old wild-type Col-0, 
orm1−/−, and orm2−/−  plants. 
The population of mutants obtained contained nucleotide deletions resulting in 
frameshifts and premature stop codons, as determined by PCR–restriction enzyme 
digestion and sequencing (Supplemental Figure 1 in Appendix A). To obtain double 
knockout mutants, we crossed the orm1−/− and orm2−/− single mutants. No progeny with 
homozygous knockout mutations in both genes were obtained after analyzing 155 plants 
from the F2 generation and 60 plants from the F3 generation. To gain more insight into 
the basis for the apparent lethality associated with the double mutant, we performed 
viability staining on pollen from plants genotyped as orm1+/− orm2+/− (Supplemental 
Figure 2A in Appendix A). Nearly all of the pollen from these mutants was viable, 
similar to pollen from the wild-type plants (Figures 2.2A and 2.2C), rather than 25% 
nonviability that would be expected for pollen lethality in this mutant. Instead, a 
population of seeds from these plants had dark colored seed coats and were severely 
wrinkled. Strikingly, free ceramide concentrations in pooled abnormal seeds were; 40-
fold higher than those in wild-type seeds and; 8-fold higher than in the normal-appearing 




Figure 2.2 Pollen Viability and Seed Development from orm1+/− orm2+/− Plants. 
(A) Representative images of pollen and anthers (treated with Alexander stain) collected from wild-type 
Col-0 and orm1+/− orm2+/− plants. (B) Viability of pollen determined by counts of ~100 pollen grains from 
five randomly selected flowers from independent Col-0 and orm1+/− orm2+/− plants. Shown are the mean ± 
SD. (C) Developing seeds in siliques from wild-type Col-0 and orm1+/− orm2+/− plants. Shriveled, brown 
(abnormal) seeds are indicated by arrows. (D) Percentage of shriveled and brown (abnormal) seeds in 
siliques determined by counts of an average of 200 developing seeds from 10 randomly selected siliques of 
the independent wild-type Col-0 and orm1+/− orm2+/− plants. Shown are the mean ± SD. Asterisks denote 
significant differences as determined by two-tailed Student’s t test, with a significance of P ≤0.01. 
This phenotype was observed for 7% of seeds collected from the F2 orm1+/− orm2+/− 
plants of orm1−/− and orm2−/− crosses, which is consistent with the expected 6.25% 
Mendelian ratio for the occurrence of homozygous double mutants. The remaining seeds 
were visually indistinguishable from wild-type seeds (Figures 2.2B and 2.2D). Of the 
seeds in these two populations, dark, wrinkled seeds did not germinate, whereas seeds 
with normal appearance showed no impairment in germination on solid Sucrose-




Figure 2.3 The ORM Double Knockout is Seed Lethal. 
(A) Seeds from wild-type Col-0; seeds from orm1+/− orm2+/− were separated and classified into normal and 
the darker, shriveled seeds as abnormal. Bars = 1 mm. (B) Phenotypes of 10-d-old seedlings from wild-type 
Col-0 seeds and normal and abnormal seeds from orm1+/− orm2+/−. Abnormal seeds did not germinate. (C) 
Ceramide content in seeds from wild-type Col-0 and normal and abnormal seeds from orm1+/− orm2+/−. 
Shown are the mean ± SD, n 5 3. Asterisks indicate significant differences based on one-way ANOVA 
followed by Tukey’s multiple comparisons test, with a significance of *, P ≤0.05 and ***, P ≤0.001. 
2.4.2 LCB1-∆TMD1 Mimics the Phenotype of the ORM-null Mutant  
We also observed a similar seed phenotype in Atlcb1+/− plants expressing a version of the 
LCB1 subunit of SPT lacking its first transmembrane domain (LCB1∆TMD1) that is 
required for SPT-ORM regulatory interactions (Han et al., 2019). In these experiments, 
the segregating seeds from Atlcb1+/− plants expressing LCB1∆TMD1 included a 
population of shrunken, nonviable seeds with a 14-fold increase in ceramide levels 




Figure 2.4 Atlcb1+/− Plants Expressing LCB1∆TMD1 Phenocopy the ORM Double Knockout Mutant. 
Figure 2.4. (A) Seeds from wild-type Col-0; seeds from Atlcb1+/− plants expressing LCB1∆TMD1 were 
separated and classified into normal and abnormal darker and shriveled seeds. Bars = 1 mm. (B) 
Phenotypes of 10-d-old seedlings from wild-type Col-0 seeds and normal and abnormal seeds from 
Atlcb1+/− expressing LCB1∆TMD1. Abnormal seeds did not germinate. (C) Ceramide content in seeds 
from wild-type Col-0 and normal and abnormal seeds from LCB1∆TMD1. Shown are the mean ± SD, n = 
3. Asterisks indicate significant difference based on one-way ANOVA followed by Tukey’s multiple 
comparisons test, with a significance of **, P ≤ 0.01. NS, not significant. 
 
We examined seeds from the orm1−/− and orm2−/− crosses and LCB1∆TMD1 in more 
detail to understand the basis for the loss of viability. The weight of mature nonviable, 
abnormal seeds was 80 to 90% lower than that of normal seed segregants from these lines 
(Figure 2.5E). Embryos dissected from the abnormal seeds had variable appearance 
ranging from cell clusters with undifferentiated appearance to embryo-like structures that 
were up to one-third the size of those from normal seeds (Figures 2.5A to 2.5D). 
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Underlying this phenotype, oil content of the abnormal seeds, as measured by the fatty 
acid content of purified triacylglycerols (TAG), was 85 to 90% lower than that of normal 
seed segregants (Figure 2.5F).  
 
Figure 2.5 Abnormal Seeds from ORM and LCB1∆TMD1 Mutant Plants Have Altered Embryo 
Morphology and Reduced TAG Concentrations. 
(A) to (D) Morphology of embryos from the wild-type seeds (A) and abnormal seeds from orm1+/− 
orm2+/−. plants (see [B] to [D]) showing that the embryo is not fully developed. Embryos were dissected 
from mature seeds. (E) The 100 seed weight. Values are the mean ± SD of seeds harvested from four 
independent plants. Asterisks indicate significant difference based on oneway ANOVA followed by 
Tukey’s multiple comparisons test, with a significance of ****, P ≤ 0.0001. NS, not significant; TMD, 
transmembrane domain. (F) TAG content in seeds from wild-type Col-0 and normal and abnormal seeds 
from orm1+/− orm2+/−. and Atlcb1+/− expressing LCB1∆TMD1. Values are the mean ± SD of three 
independent lipid extractions. Asterisks indicate significant difference based on one-way ANOVA followed 
by Tukey’s multiple comparisons test, with a significance of ***, P ≤ 0.001 and ****, P ≤ 0.0001. NS, not 
significant; TMD, transmembrane domain. (G) Composition of TAG as weight percent of fatty acid in 
seeds from wild-type Col-0 and normal and abnormal seeds from orm1+/− orm2+/−. and Atlcb1+/− 
expressing LCB1∆TMD1. Values are the mean ± SD of three independent samples. TMD, transmembrane 
domain. 
The most striking difference in fatty acid composition of TAG from the abnormal seeds 
was a reduction in the overall content of C20 and C22 very long chain fatty acids derived 
from ER-localized elongation reactions. Notably, the fatty acids 20:2, 20:3, and 22:1 
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were not detectable in TAG from the abnormal seeds (Figure 2.5G). Overall, these results 
indicate that ORMs are essential for the completion of a full life cycle in Arabidopsis. 
Lethality due to the absence of ORM proteins is associated with the recovery of 
nonviable seeds with undeveloped embryos that accumulate excessive ceramide 
concentrations and have strongly reduced TAG levels. This was phenocopied in plants 
with deregulated SPT activity due to the loss of the transmembrane domain of LCB1 that 
abolishes ORM regulation of SPT (Han et al., 2019). The identification of nearly the 
same phenotype in ORM-null mutants and LCB1-∆TMD1 lines also indicated that the 
loss of seed viability is associated with the role of ORM proteins in sphingolipid 
metabolism, rather than other reported functions of ORM in Arabidopsis (Yang et al., 
2019).  
2.4.3 The orm1+/− orm2−/− and orm1−/− orm2+/− Mutants Have Distinct Growth 
Phenotypes  
The availability of progeny from orm1−/−  and orm2−/−  crosses also allowed us to assess 
the contributions of each ORM gene to the viability and growth of Arabidopsis plants. In 
addition to our inability to obtain homozygous double mutants for these genes, we 
observed that orm1−/−  orm2+/− mutants were strongly dwarfed and senesced prior to 
flowering (Figure 2.6A). By contrast, orm1+/− orm2−/− mutants had a distinct bushy 
phenotype with overproliferation of shoots and inflorescences, delayed flowering time 
compared to wild-type and an extended life span of 7 months (Figures 2.6B and 2.6C).  
The seeds from these plants were viable and rendered 82 % plants genotyped as orm1+/+ 




Figure 2.6 orm1+/− orm2−/−  and orm1−/− orm2+/− Plants Have Distinct Growth Phenotypes. 
(A) Representative image of 35-d-old orm1+/− orm2−/− and orm1−/− orm2+/−plants. The 
orm1−/−orm2+/−plants showed reduced size and yellow regions corresponding to cell death. (B) 
Representative image of 18-d-old wild-type Col-0 and orm1+/−orm2−/− plants. Mutants showed reduced 
size, abnormal leaf shape, and a bushy phenotype. (C) Representative image of 50-d-old orm1+/−orm2−/− 
and orm1+/−orm2+/−plants. The orm1+/− orm2−/−plants showed a bushy phonotype and delayed 
flowering. (D) Representative image of 80-d-old orm1+/−orm2−/− plant. (E) Representative image of 120-
d-old orm1+/−orm2−/− plant.  
Sphingolipidomic profiling revealed little differences in the concentrations of free LCBs, 
the LCB-phosphate (LCB-P) and ceramides among the wild-type, orm1+/− orm2+/−, 
orm1−/+ orm2−/− and one plant of the genotype orm1−/−orm2+/−. However, one plant 
genotyped orm1−/−orm2+/− (2) showed increased levels of LCBs and ceramides (Fig 
2.7A, 2.7B and 2.7C). The ceramide profile of this plant with increased sphingolipid 





Figure 2.7 LCB and Ceramide Profiles in orm1+/− orm2+/−, orm1+/− orm2−/− and orm1−/−  orm2+/− 
Plants. 
(A) Free LCB composition (d18:0, d18:1, t18:0, t18:1), (B) free LCB-phosphate (LCB-P) and (C) total 
ceramide content in two representative plants of each genotype: wild-type Col-0, orm1+/− orm2+/−, orm1+/− 
orm2−/−and orm1−/−  orm2+/−. (D) and (E) Ceramide molecular species compositions representing the exact 
pairings of LCB and fatty acid for the wild-type (D), orm1−/− orm2+/−(E) plants.  
2.5 Discussion  
Our findings identified the essential role of sphingolipid biosynthetic regulation at 
the level of SPT for seed viability, which was previously unclear due to the lack of 
complete knockout mutants for ORM genes in plants. We showed that orm1−/− orm2−/− 
seeds have impaired embryo development accompanied by hyperaccumulation of the 
cytotoxic sphingolipid biosynthetic intermediates ceramides. Strongly enhanced ceramide 
accumulation was also observed in the S. cerevisiae orm1∆/orm2∆ mutant (Breslow et 
al., 2010; Han et al., 2010) and recently in Ormdl1/3 mutant mice (Clarke et al., 2019). 
We also confirmed that impaired seed viability in the mutant is due solely to the function 
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of ORMs in SPT regulation, rather than other ascribed ORM functions (Yang et al., 
2019). This was achieved by mimicking this phenotype by removing the first 
transmembrane domain of LCB1, which is required for ORM binding to SPT (Han et al., 
2019).  
This study emphasizes that the full significance of ORMs to plant viability can 
only be assessed by complete knockout of the corresponding genes. By contrast, 
Arabidopsis ORM suppressed plants previously generated by RNAi or artificial 
microRNA methods were fully viable, although the response to bacterial pathogens was 
altered in these plants and early senescence was observed with the most extreme 
suppression of ORM expression (Kimberlin et al., 2016; Li et al., 2016). Similar to our 
findings, a recent report revealed the inability to recover mice lacking all three ORMDL 
genes (Clarke et al., 2019). However, we were able to more precisely determine that 
lethality occurs during seed development rather than during gametogenesis. This finding 
contrasts with those from previous studies of plants with strongly reduced sphingolipid 
biosynthetic capacity due to impaired SPT activity (Dietrich et al., 2008; Teng et al., 
2008; Kimberlin et al., 2013). In these mutants, pollen is defective in endomembrane 
formation and is unable to complete maturation. Sphingolipids accumulate to 
exceptionally high levels in Arabidopsis pollen relative to leaves (Luttgeharm et al., 
2015b; Ischebeck, 2016). As such, it is likely that pollen is able to tolerate unregulated 
sphingolipid synthesis that results from complete ORM knockout.  
The use of gene editing also allowed us to assess the redundancy of ORM1 and 
ORM2. Notably, single mutants and progeny from the crosses that genotype as orm1+/− 
orm2+/−  had an appearance similar to the wild-type plants under normal conditions. 
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However, orm1−/− orm2+/− seedlings displayed early senescence and did not flower. 
Sphingolipid analyses revealed increased ceramides and LCBs levels in one of the plants 
of this genotype (Figure 2.7). Consistent with previous reports and our findings (Chapter 
3), the accumulation of ceramides likely triggers enhanced expression of PCD-related 
genes. It is possible that the differences in sphingolipids content within the biological 
replicates was due to sample variation in terms of temporal PCD elicitation.  
By comparison, orm1+/− orm2−/− plants were fertile but had a highly bushed 
appearance, were strongly delayed in flowering (>80 d to flowering) and had a prolonged 
life span of ~7 months.  Despite the phenotypic differences no changes were seen in the 
levels of sphingolipids in the orm1+/− orm2−/− mutants compared to wild type. It is 
important to note that the sphingolipid measurements were performed using leaves, 
perhaps significant changes in sphingolipid concentrations can be detected in specific 
cells like axillary buds that are groups of meristematic cells located in the leaf axis.  
The normal appearance of mutants genotyped as ORM1/orm2−/− and orm1−/−/ORM2 
suggests that ORM1 and ORM2 are functionally redundant, despite the phenotypic 
differences observed in orm1−/− orm2+/− and orm1+/− orm2−/− seedlings. However, it is 
possible that ORM1 and ORM2 have specific roles allowing a fine tuning of SPT activity 
through different mechanisms under specific physiological demands. Our studies indicate 
that ORM1 may be a more potent inhibitor of SPT or perhaps the stronger phenotype 
associated with the complete ORM1 knockout in the ORM2 heterozygous background 
reflects the finding that ORM1 is more highly expressed than ORM2 throughout the plant 
except in pollen (Kimberlin et al., 2016). The phenotype of the orm1+/− orm2−/− mutant 
suggests that ORM2 could contribute to the prolonged life cycle of an Arabidopsis plant 
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perhaps by cell type-specific function to fine-tune sphingolipid levels or through a 
nonsphingolipid-related function. It has been shown that mutations that lead to prolonged 
shoot apical meristems (SAM) activity, continuous generation of new shoots and arrest 
senescence of tissues are associated with extended longevity of Arabidopsis (Gan, 2003; 
Nooden and Penney, 2001). Moreover, in future work we will determine changes in 
phytohormones levels in the mutants. The roles of the hormones auxin and cytokinins are 
essential for apical dominance and the suppression of axillary buds (Guo and Gan, 2011). 
In this context it is possible that ORM2 has a functional role at the meristematic cells 
related to the transport of phytohormones.  
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3 Chapter 3. Compromised regulation of SPT activity leads to hyperaccumulation 
of selected sphingolipids, altered organellar structures and transcriptional 
regulation. 
The content included in this chapter has been published. 
Ariadna Gonzalez-Solis, Gongshe Han, Lu Gan, Yunfeng Li, Jonathan 
E. Markham, Rebecca E. Cahoon, Teresa M. Dunn, Edgar B. Cahoon. Unregulated 
Sphingolipid Biosynthesis in Gene-Edited Arabidopsis ORM Mutants Results in 
Nonviable Seeds with Strongly Reduced Oil Content. The Plant Cell Aug 
2020, 32 (8) 2474-2490; DOI: 10.1105/tpc.20.00015. 
3.1 Abstract  
Serine palmitoyltransferase, the first enzyme of sphingolipid biosynthesis, is negatively 
regulated by ORM proteins. However, in multicellular eukaryotes the mechanisms of this 
regulation are not fully understood, especially the details of the SPT-ORMs interaction 
are not known. In this study, through gene editing, we recovered the orm1∆met/∆met 
orm2−/− mutant, which expresses an ORM1 structural variant lacking one amino acid 
(Met-51). This mutant did not advance beyond the seedling stage, hyperaccumulated 
ceramides, and showed altered organellar structures and increased senescence- and 
pathogenesis-related gene expression. These seedlings also showed upregulated 
expression of genes for sphingolipid catabolic enzymes, pointing to additional 
mechanisms for maintaining sphingolipid homeostasis. Moreover, ORM1 lacking Met-51 
had strongly impaired interactions with LCB1 in a yeast (Saccharomyces cerevisiae) model, 
providing structural clues about regulatory interactions between ORM and SPT. 
3.2 Introduction 
Sphingolipids have been recognized as abundant membrane components that play several 
roles in plant cells. Besides their importance in endomembrane trafficking and formation 
of plasma membrane domains, sphingolipids are also bioactive molecules that participate 
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in signaling pathways during the pathogen-induced hypersensitive response, abiotic stress 
and ABA-dependent guard cell closure (Coursol et al., 2003; Magnin-Robert et al., 
2015). Therefore, the study of sphingolipid metabolism has become an active are of 
research in the last decades, especially the emphasis on the regulatory processes that 
ensure homeostasis during cell development and responses to the environment. As the 
first step in the pathway, serine palmitoyltransferase (SPT) is considered a target for 
regulation. Small subunits of SPT (ssSPT) interact with the core subunits of SPT, LCB1 
and LCB2, and have an activating effect on the activity (Kimberlin et al., 2013). 
Whereas, ORM proteins are negative regulators. Studies of yeast mutants have shown 
ORMs are downstream of a Torc2/Ypk1 kinase signaling pathway that senses 
sphingolipid availability and regulates SPT activity accordingly (Roelants et al., 2011). In 
the yeast regulatory scenario, under sphingolipid depletion ORMs get phosphorylated 
relieving SPT inhibition. However, in multicellular eukaryotes, the lack of the N-terminal 
domain containing the phosphorylation sites suggests the regulation of SPT by ORMs 
occurs through different mechanisms that have not been fully elucidated. Here, we 
describe an Arabidopsis mutant expressing an ORM1 structural variant that is strongly 
compromised in the regulation of SPT activity. This mutant provided valuable insights 
into changes in sphingolipid levels and the effects in the cell. These effects included 
compromised organellar structures, the induction of catabolic genes to maintain 
sphingolipid homeostasis and pathogenesis-related genes. In addition, this mutant 
provided clues about the structural requirements of ORMs for interaction with LCB1 for 




3.3 Materials and Methods  
3.3.1 Plant Materials and Growth Conditions  
Arabidopsis (Arabidopsis thaliana) Columbia-0 (Col-0) was used as the wild-type 
reference in this study. Arabidopsis seedlings were grown on Murashige and Skoog (MS) 
medium supplemented with 1% (w/v) Sucrose and 0.8% (w/v) agar, pH 5.7, with 16-h-
light (100 mmol/ m-2 s-1)/8-h-dark conditions at 22°C. The light source for growth 
chamber–grown seedlings was supplied by standard wide-spectrum fluorescent bulbs 
type F32/841/ ECO 32 W (maximum intensity, 480 to 570 nm). For Arabidopsis plants in 
soil, seeds were sown, and after 2 d of stratification at 4°C, plants were grown at 22°C 
with 16-h-light (100 mmol/ m-2 s-1)/8-h-dark conditions.  
3.3.2 Generation of CRISPR/Cas9 ORM Mutants  
For CRISPR/Cas9-mediated gene editing of ORM1 and ORM2, designed target sites (Fig 
2.1A) were fused with a single guide RNA and expressed under the control of the U6 
promoter. The egg cell–specific EC1 promoter was used to drive Cas9 expression as 
previously reported by Wang et al. (2015). In short, BsaI sites were incorporated by PCR 
into the ORM target sequences (primers P1 to P4; Supplemental Table 1 in Appendix A). 
The purified PCR products were digested with BsaI and ligated to the BsaI-linearized 
binary vector pHEE401E. The final CRISPR/Cas9 binary vector was electroporated into 
Agrobacterium tumefaciens strain GV3101 and then transformed into the Arabidopsis 
Col-0 wild-type plants via the floral dip method (Clough and Bent, 1998). The seeds were 
screened for hygromycin resistance on MS plates containing 25 mg/L hygromycin. For 
genotyping, fragments including the target regions of ORM1 and ORM2 were amplified 
by PCR from the genomic DNA of transgenic plants (primers P5 to P8; Supplemental 
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Table 1 in Appendix A). Amplicons were digested with the restriction enzymes BslI 
(ORM1) and DraIII (ORM2). The specific indels were identified by DNA sequencing. To 
analyze for nontransgenic plants, progeny of hygromycin-selected and confirmed 
homozygous (CRISPR/Cas9 mutation) T1 plants were sown directly on soil without 
hygromycin selection. These plants were then screened by PCR (P9+P10; Supplemental 
Table 1 in Appendix A) for the lack of the Cas9 gene with the presence of the CRISPR 
mutation, in the T2 generation. The plants lacking Cas9 but containing the CRISPR 
mutation were kept and used for further studies as mutated but not transgenic lines.  
3.3.3 Genetic Complementation of orm1∆met/∆met orm2−/− 
For genetic complementation of the mutant orm1∆met/∆met orm2−/−, ORM1 cDNA was 
synthesized with included silent mutations of the ORM1 gRNA target sequence to 
mitigate possible editing of the transgene. The cDNA was amplified by overlapping PCR 
and cloned into the EcoRI and XbaI sites of binary vector pBinGlyRed3 under the control 
of the native ORM1 promoter 600-bp region upstream of the ORM1 start codon (primers 
P11 to P16; Supplemental Table 1 in Appendix 1). orm1∆met/∆met orm2−/−  plants were 
transformed with the pBinGlyRed3-ORM1 construct by the floral dip method (Clough 
and Bent, 1998). Transformants were selected based on Discosoma red fluorescent 
protein fluorescence and genotyped. Mutation was confirmed by sequencing. 
3.3.4 RNA Isolation and Quantitative RT-PCR 
RNA was extracted from 12- to 15-d-old Arabidopsis seedlings grown on solid MS 
medium. Each replicate corresponds to pooled seedlings from independent plates. RNA 
extraction was performed using an RNeasy Kit (Qiagen) according to the manufacturer’s 
protocol. The isolated RNA (1mg) was treated with DNase I (Invitrogen). cDNA 
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conversion was performed with a RevertAid cDNA synthesis kit (Thermo Fisher 
Scientific). SYBR Green was used as the fluorophore in a qPCR supermix (Qiagen). 
PP2AA3 and UBIQUITIN (UBQ) were used as internal reference genes. qPCR was 
performed using a Bio-Rad MyiQ iCycler qPCR instrument. The thermal cycling 
conditions were an initial step of 95°C for 10 min followed by 45 cycles at 95°C for 15 s, 
60°C for 30 s, and 72°C for 30 s. Primers used in this study are listed in Supplemental 
Table 1 in Appendix 1. 
3.3.5 Electron Microscopy 
Ten-day-old wild-type and orm1∆met/∆met orm2−/−  seedlings were used for TEM. The 
samples were cut and fixed with 2.5% (v/v) glutaraldehyde and 2.0% (v/v) 
paraformaldehyde in 0.1 M cacodylate buffer. The samples were subjected to postfixation 
with 1% (w/v) osmium tetroxide in 0.1 M cacodylate buffer, dehydrated with ethanol and 
acetone, and embedded with a Spurr’s Embedding Kit. Ultrathin sections (100 nm) were 
cut and stained with uranyl acetate and lead citrate. Samples were imaged on a Hitachi 
H7500 transmission electron microscope at an accelerating voltage of 80 kV. 
3.3.6 Sphingolipid Extraction and Analysis 
Sphingolipids were extracted as described in Markham and Jaworski (2007). Briefly, 12- 
to 15-d-old Arabidopsis seedlings grown on solid medium were collected from 
independent plates for each biological replicate. The seedlings were lyophilized, and 10 
to 30 mg of tissue was homogenized and extracted with isopropanol:heptane:water 
(55:20:25, v/v/v). We used 1 to 4 mg of plant material for each biological replicate for 
sphingolipid analysis from seeds. Internal standards for the different sphingolipid classes 
were added. The supernatants were dried and deesterified with methylamine in 
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ethanol:water (70:30, v/v). The lipid extract was re-suspended in 
tetrahydrofuran:methanol:water (5:2:5, v/v/v) containing 0.1% (v/v) formic acid. The 
sphingolipid species were analyzed using a Shimadzu Prominence ultra-performance 
liquid chromatography system and a 4000 QTRAP mass spectrometer (AB SCIEX). Data 
analysis and quantification were performed using the software Analyst 1.5 and 
MultiQuant 2.1 as described by Markham and Jaworski (2007), Kimberlin et al. (2013), 
and Davis et al. (2020). 
3.3.7 Saccharomyces cerevisiae Cell Growth and Expression Plasmids  
Saccharomyces cerevisiae strain TDY9113 (Mata tsc3D:NATlcb1D:KAN ura3 leu2 lys2 
trp1D) lacking endogenous SPT was used for the expression of Arabidopsis SPT subunits 
and ORM proteins as described by Kimberlin et al. (2016). For DoxSA quantification, S. 
cerevisiae strain TDY9113 expressing AtLCB1C144W was grown in 1.5% (w/v) Gal and 
0.5% (w/v) Glc supplemented with 40 mM Ala. Plasmids for the expression of AtLCB1- 
FLAG, Myc-AtLCB2a, and HA-AtssSPTa in S. cerevisiae were as described by 
Kimberlin et al. (2013) and for HA-AtORM1 as described by Kimberlin et al. (2016). 
AtLCB1C144W was generated by QuikChange mutagenesis (Agilent Technologies) and 
confirmed by sequencing. The open reading frame of AtORM1∆Met51 was amplified by 
PCR and inserted into pPR3-N (Dualsystems Biotech) for expression with an N-terminal 
HA tag. LCB and DoxSA quantifications were performed as previously described by 
Kimberlin et al. (2016). 
3.3.8 Immunoprecipitation 
Microsomal membrane proteins were prepared from S. cerevisiae cells expressing 
FLAG-tagged AtLCB1, Myc-tagged AtLCB2a, HA-tagged AtssSPTa, and HA-tagged 
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AtORM1 or AtORM1∆Met51. Microsomal membrane proteins were solubilized in 1.5% 
digitonin at 4°C for 2.5 h and incubated with FLAG-beads (Sigma-Aldrich) overnight. 
The bound proteins were eluted in immunoprecipitation buffer (50 mM Hepes-KOH, pH 
6.8, 150 mM potassium acetate, 2 mM magnesium acetate, 1 mM calcium chloride, and 
15% [v/v] glycerol) containing 0.25% (w/v) digitonin and 200 mg/mL FLAG peptide, 
resolved on a 4 to 12% (w/v) Bis-Tris NuPAGE gel (Invitrogen), and detected by 
immunoblotting with anti-HA (1:5000 dilution; Covance), anti-Myc (1:3000 dilution; 
Sigma-Aldrich), and antiFLAG (1:5000 dilution; GenScript) antibodies. 
3.3.9 Membrane Topology Mapping of AtORM1∆Met51  
AtORM1 or AtORM1∆Met51-encoding synthetic cDNAs with an in-frame glycosylation 
cassette (GC) inserted after codon 46, 82 or 121 were synthesized by GenScript and 
ligated into pPR3-N for expression with an N-terminal HA tag. The HA-ORM1-GC–
tagged proteins were expressed (along with AtLCB1-FLAG, MYC-AtLCB2a, and HA-
AtssSPTa) in S. cerevisiae strain TDY9113. Isolation of microsomal proteins, digestion 
with endoglycosidase H, and immunodetection of the AtORM1 proteins were performed 
as previously described (Kimberlin et al., 2016).  
3.3.10  Statistical Analyses 
Two-tailed Student’s t test was performed to evaluate statistically significant differences 
compared to the control (wild type). One-way ANOVA followed by Tukey’s test was 
used to determine the differences among the five genotypes for a given variable. Values 
of P ≤ 0.05 were considered statistically significant. The statistical analyses were done 
using GraphPad Prism 8.3.0.  
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3.4 Results  
3.4.1 orm1∆met/∆met orm2−/− Mutant Does Not Survive Beyond the Seedling Stage 
Screening of gene-edited lines revealed a mutant with an in frame deletion of a single 
codon that resulted in a deletion of the Met residue at amino acid 51 relative to the wild-
type ORM1 (Figure 3.1B). This line also carried nucleotide deletions in ORM2 that led to 
a frameshift and premature stop codon (Supplemental Figures 1 and 2B in Appendix 1). 
Seedlings with the genotype orm1∆met/∆met orm2+/− showed a phenotype like the wild type 
and the single mutants under normal growth conditions (Figure 3.1A). However, we 
could only recover plants of the genotype orm1∆met/∆met orm2−/− in solid medium 
supplemented with Sucrose. The resulting seedlings were severely dwarfed and had a 
proliferation of small, deformed chlorotic leaves. These plants persisted in a visually 
viable state for 20 to 25 d after planting, but did not progress beyond the seedling stage, 
indicating that the orm1∆met/∆met orm2−/− mutation is seedling lethal (Figures 3.1A and 
3.1C to 3.1F). Complementation of this mutant with the Arabidopsis ORM1 cDNA under 
the control of its native promoter was sufficient to rescue the seedling lethality and 
recover fertile plants, although many of the independent complemented mutant lines were 
smaller than wild-type plants, which is similar to the phenotype of orm1+/− orm2−/− 





Figure 3.1  orm1∆met/∆met orm2−/− Plants Exhibit Developmental Defects and Do Not Progress beyond 
the Seedling Stage. 
(A) and (C) to (E) Representative images (A) of the 12-d-old wild-type Col-0, orm1−/−, orm2−/−, 
orm1∆met/∆met orm2+/−, and orm1∆met/∆met orm2−/−seedlings. Seedlings with the same phenotype as the wild 
type correspond to orm1∆met/∆met orm2+/−; small seedlings showing developmental defects correspond to 
orm1∆met/∆met orm2−/−; enlarged images are shown in (C) to (E). Bars = 1 mm. (B) CRISPR/Cas9-induced 
mutations in ORM1 and ORM2. Structures of the ORM genes; black boxes represent exons. The position of 
the CRISPR target site is marked as well as the nucleotide deletions in each mutant. (F) Phenotypes of 18-
d-old seedlings; arrows indicate orm1∆met/∆met orm2−/−and asterisk indicates orm1∆met/∆met orm2+/−. Bar = 1 
mm. 
3.4.2 orm1∆met/∆met orm2−/− Mutant Hyperaccumulates Selected Sphingolipids 
 Based on the finding that downregulating ORM expression triggers sphingolipid 
accumulation (Breslow et al., 2010; Kimberlin et al., 2016; Li et al., 2016), we conducted 
extensive sphingolipidomic profiling of our gene-edited mutants from seedlings grown on 




Figure 3.2  Selected Sphingolipid Classes Highly Accumulate in the orm1∆met/∆met orm2−/− Mutant. 
 (A) to (G) Total sphingolipid content (A) in wild-type, orm1−/−, orm2−/−, orm1∆met/∆met orm2+/−, and 
orm1∆met/∆met orm2−/−. Content of the following sphingolipid classes in the mutants: free LCBs (B), Cer 
(Ceramides; see [C]), hCer (hCeramides; see [D]), GlcCer (E), and GIPCs (F). Content of atypical 
sphingolipids nh-GlcCer (G) and IPCs (H). (I) Content of atypical deoxyLCB m18:0 in ceramides. 
Normally, SPT condenses Ser with palmitoyl-CoA to form d18:0. However, the unusual condensation of 
Ala gives rise to a deoxyLCB, DoxSA m18:0. Measurements are the average of four to six replicates 
consisting of pooled 12- to 15-d-old seedlings grown on different plates. Bars represent SE of the mean. 
Different letters indicate significant difference based on one-way ANOVA followed by Tukey’s multiple 
comparisons test (P ≤ 0.05). 
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The orm1∆met/∆met orm2−/− mutant accumulated 3.7-fold more sphingolipids than 
wild-type seedlings (Figure 3.2A). No significant differences in the levels of free LCBs, 
ceramides with nonhydroxylated fatty acids (Cer), or other sphingolipid classes were 
detected in the orm1−/−, orm2−/−, or orm1∆met/∆met orm2+/− mutants compared to wild-type 
plants (Figures 3.2B to 3.2E and 3.G to 3.2I). In strong contrast, orm1∆met/∆met orm2−/− 
seedlings showed heightened accumulation of LCB (5-fold), Cer (90-fold), and ceramides 
with hydroxylated fatty acids (hCer; 12-fold) compared to wild-type seedlings of similar 
age (Figures 3.2B and 3.2D; Supplemental Figure 4 in Appendix 1). Although no changes 
were detected in GlcCer concentrations, the levels of GlcCer containing nonhydroxylated 
fatty acids (nhGlcCer), not typically found in abundance in Arabidopsis, were 13-fold 
higher in orm1∆met/∆met orm2−/− seedlings than in wildtype seedlings (Figures 6E and 6G; 
Supplemental Figures 5 and 6). GIPC levels increased by 48% in the orm1∆met/∆met 
orm2−/− mutant compared to wild-type seedlings (Figure 3.2F; Supplemental Figure 7 in 
Appendix 1). The LCB composition of the single mutants and orm1∆met/∆met orm2+/− did 
not change significantly compared to wild type (Figures 3.3A and 3.3B). However, in 
orm1∆met/∆met orm2−/−, the levels of free and phosphorylated forms of d18:0 were the most 
strongly increased, with lesser increases in the amounts of t18:0 and t18:1 free and 
phosphorylated species (Figures 3.3A and 3.3B). Cer profiles of the single mutants were 
similar to those of the wild type (Figures 3.3C to 3.3E). By contrast, the orm1∆met/∆met 
orm2+/− mutant had increased amounts of Cer with C16 fatty acids relative to wild-type 
and single mutant plants (Figure 3.3F). This phenotype was more accentuated in 
orm1∆met/∆met orm2−/− seedlings, which primarily accumulated Cer species with C16 fatty 
acids linked to the dihydroxy LCB d18:0 and d18:1 (Figure 3.3G). Increased amounts of 
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Cer with C22, C24, and C26 fatty acids as well as atypical C18 and C20 fatty acid– 
containing species were also detected in orm1∆met/∆met orm2−/− seedlings relative to wild-
type plants and mutants of either ORM gene (Figure 3.3G). 
 
Figure 3.3 Free LCB and Ceramide Compositions and Concentrations Are Strongly Affected in the 
orm1∆met/∆met orm2−/− Mutant. 
(A) to (G) Free LCB composition (d18:0, d18:1, t18:0, t18:1, [A]) and free LCB-phosphate (LCB-P) 
composition in the wild-type, orm1−/−, orm2−/−, orm1∆met/∆met orm2+/−, and orm1∆met/∆met orm2−/−. (B). Bars 
show averages of four to six replicates consisting of 12- to 15-d-old pooled seedlings grown on different 
plates. Error bars represent the SE of the mean. Different letters indicate significant difference, for each 
LCB, based on one-way ANOVA followed by Tukey’s multiple comparisons test (P ≤0.05). Ceramide 
molecular species compositions representing the exact pairings of LCB and fatty acid for the wild-type (C), 
orm1−/−, (D), orm2−/−, (E), orm1∆met/∆met orm2+/−, (F), and orm1∆met/∆met orm2−/− (G) plants. Measurements 
for all panels are the average of four to six replicates consisting of 12- to 15-d-old pooled seedlings grown 
on different plates. Bars represent SE of the mean. 
Overall, the primary change in the composition of all sphingolipid classes, especially Cer, 
hCer, and nhGlcCer, in the orm1∆met/∆met orm2−/− seedlings was the change in the total 
and/or relative amounts of those containing C16 fatty acids bound to dihydroxy LCB, 
which are derived from the LOH2 ceramide synthase (Figure 3.3G; Supplemental Figures 
4 and 6; Markham et al., 2011; Ternes et al., 2011; Luttgeharm et al., 2015a). The 
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orm1∆met/∆met orm2−/− plants also contained aberrant forms of hCer and GIPCs with 
currently undefined structures based on liquid chromatography–mass spectrometry 
ionization as well as Cer with the LCB deoxysphinganine (DoxSA), which is derived 
from the condensation of Ala, rather than Ser, to palmitoylCoA by SPT (Figure 6I). In 
addition, the concentration of inositolphosphorylceramides (IPCs), the precursors of 
GIPCs, increased nearly 12-fold in small orm1∆met/∆met orm2−/− seedlings versus the wild 
type (Figure 6H). Overall, these findings are consistent with the notion that SPT 
regulation by the ORM1∆met-encoded polypeptide is deficient and that the flux of excess 
LCB occurs through the LOH2 ceramide synthase to produce Cer backbones with C16 
fatty acids and dihydroxy LCB, a portion of which are channeled to GIPCs but 
accumulate as IPC intermediates.  
3.4.3 Integrity of Cellular Component Is Compromised in the orm1∆met/∆met orm2−/− 
Mutant  
Given that sphingolipids are abundant endomembrane and plasma membrane components 
that contribute to vesicular trafficking, we used transmission electron microscopy (TEM) 
to evaluate the subcellular phenotypes associated with enhanced sphingolipid 
accumulation in 10-d-old orm1∆met/∆met orm2−/− seedlings relative to the wild-type 
seedlings of the same age. Mesophyll cells from the wild-type seedlings showed large 
vacuoles with turgor pressure pushing organelles to the periphery (Figure 3.4A). 
Chloroplasts of the wild-type cells had the typical oval shape and well-defined thylakoid 




Figure 3.4 Subcellular Features are Strongly Altered in the orm1∆met/∆met orm2−/− Mutant. 
(A) to (H) Representative TEM images of the wild-type seedlings (see [A] and [B]) and orm1∆met/∆met 
orm2−/−. (see [C] to [I]). Longitudinal sections of leaves from 10-d-old seedlings were prepared for TEM 
analysis. Boxes represent sections enlarged in (E) and (H). Asterisks indicate vesicles and arrows 
autophagosomes. Bar = 200 nm in (I); bars = 800 nm in (E) and (F); bar = 1mm in (B); bars = 2mm in (A) 
and(C); and bars = 4mm in (D) and (G). Ch, Chloroplast; CW, cell wall; GA, Golgi apparatus; M, 
mitochondrion; V, vacuole. 
displayed a lack of vacuolar turgor (Figure 3.4D). In addition, chloroplasts of 
orm1∆met/∆met orm2−/− cells were round and showed marked disintegration of thylakoids 
and highly abundant osmiophilic structures that resemble plastoglobuli (Figures 3.4C to 
3.4F). Notably, increased vesicle numbers were observed around the ER network in 
orm1∆met/∆met orm2−/− cells (Figure 3.4F). Furthermore, electrodense material and double 
membrane vesicles consistent with autophagosomes were detected inside the vacuoles of 
these cells. Moreover, entire chloroplasts were engulfed and appeared to be in the process 
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of degradation (Figures 3.4G and 3.4H). Despite these large defects, Golgi stacks were 
detectable in orm1∆met/∆met orm2−/− cells (Figure 3.4I). 
3.4.4 Genes for Ceramide Synthases, LCB Kinase, and LCB-Phosphate Lyase Are 
Upregulated in the orm1∆met/∆met orm2−/− Mutant  
Given the increased concentrations of most sphingolipid classes in orm1∆met/∆met orm2−/−, 
we examined the expression of genes in 12-d-old seedlings for key sphingolipid 
biosynthetic and catabolic enzymes, including the SPT-associated polypeptides LCB1 
and ssSPTa, ceramide synthases (LOH1, LOH2, and LOH3), sphingosine kinases 
(SPHK1 and SPHK2), and the LCB catabolic enzyme LCB-phosphate lyase (or DPL1). 
No significant differences were detected in the expression of genes for LCB1, ssSPTa, or 
LOH1 in any mutant analyzed (Supplemental Figures 8A to 8C in Appendix 1). 
However, consistent with the increased amounts of ceramides in orm1∆met/∆met orm2−/−, 
the ceramide synthase gene LOH2 showed a 2.5-fold increase in expression and the 
ceramide synthase gene LOH3 showed a 2-fold increase in orm1∆met/∆met orm2−/− plants 
compared to the wild type and the other mutants examined (Figures 3.5A and 3.5B). 
Most notably, the expression of the key sphingolipid catabolism-associated genes SPHK2 
and DPL1 increased by approximately six- to sevenfold, respectively, in orm1∆met/∆met 
orm2−/− plants relative to the wild type and other ORM mutants (Figures 3.5C and 3.5D). 
This result is consistent with the notion that the induction of LCB catabolism is one route 
(in addition to ceramide biosynthesis) for the mitigation of unregulated LCB production 





Figure 3.5 Expression of Genes Associated with Sphingolipid Homeostasis, Plant Defense Responses, 
and Senescence are Upregulated in the orm1∆met/∆met orm2−/− Mutant. 
(A) to (H) Wild-type, orm1−/−, orm2−/−, orm1∆met/∆met orm2+/−, and orm1∆met/∆met orm2−/−. seedlings of 12-d-
old plants were used to examine gene expression by qPCR to monitor genes encoding enzymes in 
sphingolipid biosynthetic and catabolic pathways: ceramide synthase gene LOH2 (A), ceramide synthase 
gene LOH3 (B), sphingosine kinase 2 gene SPHK2 (C), and LCB-phosphate lyase gene DPL1 (D) and 
selected pathogenesis- and senescence-related genes: β-1,3-glucanase gene PR2 (E), class III peroxidase 
gene PRXC (F), flavin monooxygenase gene FMO (G), and senescence-related 13 gene SAG13 (H). 
PP2AA3 transcript levels were used as a control for the sphingolipid genes and UBQ for the pathogenesis- 
and senescence-related genes. Specific primers used for this analysis are shown in the Supplemental Table 
1 in Appendix 1. Gene expression levels are normalized to those in wild-type seedlings. Values are the 
mean ± SD (n = 6 to 12). Different letters indicate significant difference based on one-way ANOVA 
followed by Tukey’s multiple comparisons test (P ≤ 0.05). 
3.4.5 Defense and Senescence Genes Are Upregulated in the orm1∆met/∆met orm2−/− 
Mutant  
The accumulation of ceramides has been linked to the activation of signaling pathways 
that lead to PCD (Liang et al., 2003; Bi et al., 2014). To examine whether the high 
amounts of ceramides in orm1∆met/∆met orm2−/− activate PCD, we performed qPCR of 
marker genes using RNA extracted from 12-d-old seedlings. The expression of the 
pathogenesis-related genes (PR-2, PRXC, FMO, PR3) was significantly higher in 
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orm1∆met/∆met orm2−/− than in the wild type and the other mutants (Figures 3.5E to 3.5G; 
Supplemental Figure 8E in Appendix 1). A similar expression pattern was also observed 
for the senescence-related gene SAG13 (Figure 3.5H).  
3.4.6 ORM1∆Met51 Fails to Interact with LCB1 to Suppress SPT Activity 
 Our results clearly show that ORM1 lacking Met-51 is strongly impaired in repressing 
SPT activity. This amino acid is located in the ER luminal domain immediately adjacent 
to the second transmembrane domain of ORM1 (Supplemental Figure 9 in Appendix 1). 
We hypothesized that, without this amino acid, the conformation of the second 
transmembrane domain of ORM1 is altered such that the interaction with LCB1 for the 
repression of SPT activity is disrupted.  
 
Figure 3.6 Expression of AtORM1∆Met51 in yeast 
(A) AtORM1∆Met51 was stably expressed in S. cerevisiae with the native SPT complex replaced by the 
Arabidopsis SPT complex (see Methods). AtLCB1- FLAG, MYC-AtLCB2a, and HA-AtssSPTa without or 
with HA-AtORM1 or HA-AtORM1∆Met51were expressed in S. cerevisiae strain lcb1 tsc3. Five, 10, and 15 
mg of microsomal proteins was loaded and analyzed by SDS-PAGE (4 to 12%; Invitrogen) and detected 
with anti-LCB1 (1:3000) and anti-HA (Covance) antibodies. (B) DoxSA levels were determined from cells 
expressing AtLCB1C144W and AtLCB2a, HA-AtssSPTa along with vector, HA-AtORM1 wild-type, or 
HAAtORM1∆Met51. Shown are the mean ± SD of DoxSA levels from six independent colonies for each 
strain. Asterisks denote significant differences, as determined by two-tailed Student’s t test with a 
significance of P ≤ 0.001; NS, not significant, n=6. 
 To better understand this regulatory mechanism, we stably expressed the Arabidopsis 
ORM1∆Met51 mutant protein in an S. cerevisiae mutant background in which AtLCB1, 
70 
 
AtLCB2, and AtssSPTa replaced the corresponding S. cerevisiae SPT-associated 
polypeptides, as confirmed by immunoblotting (Figure 3.6A). 
We assessed in vivo SPT activity by measuring the DoxSA produced when expressing 
AtLCB1C144W (Figure 3.6B). DeoxyLCBs cannot be phosphorylated/degraded and are 
used as a readout for in situ SPT activity (Gable et al., 2010; Kimberlin et al., 2016). 
When expressed in this S. cerevisiae background, the wild-type Arabidopsis ORM1 was 
able to suppress DoxSA production, which is consistent with its function as a negative 
regulator of SPT activity. By contrast, DoxSA concentrations in AtORM1∆Met51-
expressing cells were similar to those in vector control cells lacking ORM1, which is 
consistent with a lack of repressed SPT activity. ORMs interact with the first 
transmembrane domain of LCB1 to repress SPT activity in S. cerevisiae (Han et al., 
2019), although the structural components of ORM associated with this interaction have 
not been defined. To test whether AtORM1∆Met51 physically interacts with AtLCB1, as 
does the wild-type ORM1, we performed coimmunoprecipitation of FLAG-tagged 
AtLCB1 with solubilized microsomes from S. cerevisiae cells expressing Myc-AtLCB2a, 
hemagglutinin (HA)-AtssSPTa, and HA-AtORM1 or HA-AtORM1∆Met51.  
Pull-downs of AtLCB1 resulted in coimmunoprecipitation of AtLCB2a and AtORM1, 
but not ELO3, an ER protein that does not interact with SPT. By contrast, only trace 
amounts of HA-AtORM1∆Met51 were detected in the AtLCB1 pulldowns (Figure 3.7A). 
This finding indicates that Met-51 is critical for the ORM-LCB1 physical interaction to 
regulate SPT activity. To determine whether the impaired ORM-LCB1 interaction is due 
to gross or subtle alterations in the secondary structure of ORM induced by the Met51 




Figure 3.7 AtORM1∆Met51 Fails to Regulate SPT Activity and Does Not Interact with LCB1. 
(A) Coimmunoprecipitation of FLAG-tagged AtLCB1 in S. cerevisiae expressing AtLCB1-FLAG, MYC-
AtLCB2a, HA-AtssSPTa, and either HA-AtORM1 or HA-AtORM1DMet51. Solubilized S. cerevisiae 
microsomes were incubated with anti-FLAG beads, and protein was eluted with FLAG peptide. Solubilized 
microsomes (Input), unbound and bound (IP-FLAG) were analyzed by immunoblotting. ELO3, an integral 
ER membrane protein, was used as a negative control. (B) Topology mapping of AtORM1DMet51. GCs 
were inserted after the indicated amino acids, and the GC-tagged proteins were expressed in S. cerevisiae. 
Increased mobility following treatment of microsomes with endoglycosidase H (Endo H) revealed that the 
GCs at residues 46 and 121 are glycosylated and therefore reside in the lumen of the ER. However, the GC 
at residue 82 is not glycosylated, indicating that residue 82 is located in the cytosol. AtORM1∆Met51 retains 
the topology of wild-type (WT) ORM1. 
We inserted glycosylation cassettes into the two predicted ER luminal loops (at amino 
acids 46 and 121) and into the cytosolic loop between the second and third 
transmembrane domains (at amino acid 82) and expressed the proteins in S. cerevisiae 
along with reconstituted Arabidopsis SPT. The analysis showed that the cassettes in the 
predicted luminal domains were glycosylated, while the cassette in the predicted 
cytosolic domain was not (Figure 3.7B). Thus, we conclude that ORM1 with the Met51 
deletion retains the topology of wild-type ORM1. 
3.5 Discussion 
Among the gene-edited ORM variants identified in our studies was a mutant that 
contained an in-frame deletion of Met-51 combined with a homozygous knockout of 
ORM2 (orm1∆met/∆met orm2−/−). Seeds from this mutant were viable, in contrast to orm1−/− 
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orm2−/−; however, the plants did not advance beyond the seedling stage and had strong 
developmental defects. Like the orm1−/− orm2−/− seeds, the orm1∆met/∆met orm2−/− 
seedlings hyperaccumulated ceramides with C16 fatty acids. These seedlings also 
accumulated aberrant sphingolipids including DoxSA containing ceramides, GlcCer 
containing nonhydroxylated fatty acids, and IPCs, all of which were nearly absent from 
wild-type seedlings. Cells from the orm1∆met/∆met orm2−/− seedlings displayed gross 
defects in membrane and organellar structures as well as apparent autophagosome-like 
structures. The early cell death displayed by the orm1∆met/∆met orm2−/− seedlings can be 
attributed to the activation of PCD pathways, as indicated by the high transcript levels of 
pathogenesis- and senescence-related genes that have been shown to be activated by the 
accumulation of LCB and ceramides. Notably, Met-51 is predicted to occur at a position 
that is adjacent to the second transmembrane domain of ORMs, but is not a conserved 
residue across eukaryotic ORM or ORMDL proteins (Supplemental Figure 9 in Appendix 
1). Using S. cerevisiae mutants containing the Arabidopsis SPT complex, we determined 
that the ORM1 Met51 mutant has greatly reduced interaction with Arabidopsis LCB1, 
which is required for ORM-induced suppression of SPT activity. Given that Met-51 is not 
conserved in eukaryotes, it is likely that LCB1 does not directly interact with this residue. 
Instead, the lack of this amino acid likely produces a conformational change at the second 
transmembrane domain of ORM that impedes its regulatory interaction with the first 
transmembrane domain of LCB1. The maintenance of the topology of ORM1∆Met51 in 
microsomal membranes was verified by endoglycosidase H digestion studies using the 
mutant ORM1 protein carrying glycosylation cassettes. To date, no residues or structural 
features in ORMs have been identified that are associated with their interaction with the 
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LCB1/ LCB2 heterodimer of SPT. Our findings point to the possible interaction of the 
first transmembrane domain of LCB1 with the second transmembrane domain of ORM as 
the basis for SPT regulation. Additional structural studies are required to fully elucidate 
these potential regulatory interactions between ORM and LCB1.  
Our results also revealed transcriptional mechanisms for maintaining sphingolipid 
homeostasis upon the enhanced production of LCBs in the orm1∆met/∆met orm2−/− mutant. 
LOH2 and LOH3 (encoding the functionally distinct ceramide synthases), SPHK2 
(enconding a LCB kinase) and DPL1 (encoding the last step in LCB degradation) were 
transcriptionally upregulated in the mutant. Notably, upregulating LOH2 expression was 
associated with the preponderance of ceramides containing C16 fatty acids and dihydroxy 
LCBs (the principal products of LOH2 ceramide synthase activity) in free ceramides and 
GlcCer, including nhGlcCer, which accumulated in orm1∆met/∆met orm2−/− seedlings but 
were detected at only low concentrations in the wild type and ORM1 and ORM2 single 
mutants. These findings are consistent with our previous report that LOH2 activity is 
upregulated in Arabidopsis ORM RNAi plants, presumably as a pathway for reducing 
cytotoxicity of free LCBs and ceramides (which are metabolized to GlcCer; Kimberlin et 
al., 2016). No changes were detected in LCB1 or ssSPTa transcript levels in the 
orm1∆met/∆met orm2−/− mutant, indicating that the transcriptional regulation of genes for 
SPT complex proteins is not a pathway for maintaining sphingolipid homeostasis in 
response to deregulated LCB biosynthesis. Instead, the expression of genes involved in 
the catabolism of LCBs increased approximately six- to sevenfold (SPHK2 and DPL1) in 
this mutant, suggesting that an unknown mechanism is activated in response to increased 
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4 Chapter 4 Investigating the physiological effects of HSAN1-like mutations in 
Arabidopsis. 
This chapter may be part of a publication in the future.  
Authors: Ariadna Gonzalez Solis, Rebecca E. Cahoon, Gongshe Han, Teresa M. Dunn, 
Edgar B. Cahoon.  
4.1 Abstract  
The deoxysphingolipids are atypical sphingolipids that are generated when serine 
palmitoyltransferase (SPT) condenses palmitoyl-CoA with alanine or glycine instead of 
serine during the synthesis. The shift in substrate specificity is associated with variants of 
SPT subunits that have specific point mutations. Even though great progress has been 
made understanding the metabolism and effects of deoxysphingolipids in the context of 
the hereditary sensory autonomic neuropathy type 1 (HSAN1) in humans, these atypical 
sphingolipids remain largely unexplored in plants.   
Here we provide insights into the physiological effects in Arabidopsis caused by 
the incorporation of the point mutations in SPT that are associated with the accumulation 
of deoxysphingolipids. Our research demonstrated that the changes in SPT resulted in 
early senescence and resistance to the cell death triggered by the mycotoxin Fumonisin 
B1.  
4.2 Introduction 
Serine palmitoyltransferase (SPT) catalyzes the first reaction of sphingolipid 
biosynthesis by condensing L-serine with palmitoyl-CoA to form sphingoid bases or long 
chain bases (LCBs), the characteristic backbone of all sphingolipids. The core SPT is a 
heterodimer formed by LCB1 and LCB2 subunits, additional regulatory proteins like 
ssSPT and ORM proteins interact with the core SPT and have an impact on its activity 
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(Tamura et al., 2001; Chen et al., 2006; Dietrich et al., 2008; Kimberlin et al., 2013; 
Kimberlin et al., 2016). Based on studies of Saccharomyces cerevisiae it is known that 
the active site of SPT is localized at the dimer interface, and LCB1 stabilizes the complex 
(Gable et al., 2002).  Moreover, several studies in Arabidopsis have shown knock-out 
mutants for the LCB2 (LCB2a and LCB2b) and LCB1 genes are not viable, emphasizing 
the importance of sphingolipids as essential components of plant cells (Tamura et al., 
2001; Chen et al., 2006; Dietrich et al., 2008). 
In humans, eight missense mutations in SPTLC1 and four mutations in the 
SPTLC2 subunits (LCB1 and LCB2 ortologues, respectively), are associated with 
Hereditary Sensory and Autonomic Neuropathy 1 (HSAN1), a rare dominantly inherited 
degenerative disorder caused by the accumulation of unusual deoxysphingolipids (Penno 
et al., 2010). All the HSAN1 mutations characterized to date induce a shift in the 
substrate specificity of SPT from L-serine to L-alanine or glycine giving rise to 1-
deoxyshinganine (1-deoxySA; m18:0) or 1-deoxymethylsphinganine (1-deoxymetylSA: 
m17:0). These atypical LCBs can get N-acylated by ceramide synthases to form 
ceramides; however, the lack of the hydroxyl group in C1 position precludes the 
formation of more complex glycosylated sphingolipids. The missing hydroxyl group also 
hampers the degradation of deoxyLCBs by the canonical pathway that requires 
phosphorylation at C1 to form the catabolic phosphorylated intermediates.  
Interestingly, out of the context of HSAN1, 1-deoxysphingolipids were also 
detected in a mammalian cell line treated with the ceramide synthase inhibitor Fumonisin 
B1 (FB1) (Zitomer et al., 2009). In this study the accumulation of canonical LCBs was 
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accompanied with 1-deoxySA suggesting that the wild-type SPT is also capable of using 
alanine and glycine as substrates.   
The study of SPT regulation requires a robust, sensitive and reproducible method 
to measure its activity. In mammalian cells and yeast, SPT activity is usually measured 
by a radioactivity-based assay using 3H or 14C-serine as substrate that gets incorporated 
into 3-ketosphinganine (Williams et al., 1984). However, measuring the activity in plants 
is still problematic due to the low activity in in vitro assays. Evidence in yeast shows the 
non-degradable deoxySA could serve as a strategy to measure SPT activity as this LCB 
accumulates and is not degraded (Chapter 3) (Gable et al., 2010; Kimberlin et al., 2016).   
For this study, we hypothesize that incorporating the HSAN1 mutations into 
Arabidopsis SPT would allow the production of deoxysphingolipids, which could be used 
as a readout for SPT activity. Moreover, the characterization of transgenic plants 
expressing mutations in LCB1 would allow us to examine the physiological effects of the 
unusual sphingolipids that until now have not been explored in plants.  
Here we describe the incorporation of the mutated versions LCB1C144W and 
LCB1C144W V155D into Arabidopsis resulting in early senescence hallmarks. We also 
determined that these plants are resistant to the mycotoxin FB1. Although we did not 
detect a significant accumulation of deoxyceramides in the transgenic plants compared to 
wild type, we observed that m18:0 and m18:1 were incorporated to ceramides containing 
C16 fatty acids. Future work will focus on the detection of potential degradation products 




4.3 Materials and Methods 
4.3.1 Plant Materials and Growth Conditions  
Arabidopsis (Arabidopsis thaliana) Columbia-0 (Col-0) was used as the wild-type 
reference in this study. Arabidopsis seedlings were grown on Murashige and Skoog (MS) 
medium supplemented with 1% (w/v) Sucrose and 0.8% (w/v) agar, pH 5.7, with 16-h-
light (100 mmol/ m-2 s-1)/8-h-dark conditions at 22°C. The light source for growth 
chamber–grown seedlings was supplied by standard wide-spectrum fluorescent bulbs 
type F32/841/ ECO 32 W (maximum intensity, 480 to 570 nm). For Arabidopsis plants in 
soil, seeds were sown, and after 2 d of stratification at 4°C, plants were grown at 22°C 
with 16-h-light (100 mmol/ m-2 s-1)/8-h-dark conditions.  
4.3.2 HSAN1 LCB1 Generation and Transformation 
Two versions of the HSAN1 mutations were generated in AtLCB1 using QuikChange 
Site-Directed Mutagenesis Kit (Stratagene), LCB1C144W an LCB1C144W V155D. The mutated 
versions of LCB1 were then cloned into the vector pBinGlyRed3 under the native LCB1 
promoter (~1kb). The Binary vectors were transformed into Agrobacterium tuumefaciens 
GV3101 by electroporation. Heterozygous LCB1 mutants (SALK_077745) were used to 
create transgenic plants by the floral dip method (Clough and Bent, 1998). Red seeds 
were screened using a green LED light and a red2 camara filter to identify transformed 
Arabidopsis seeds harboring the vector expressing DsRed.  
4.3.3 Arabidopsis Mutant Genotyping 
The T-DNA SALK_077745 insertion line was acquired from the Arabidopsis Biological 
Resource Center.  Individual plants from a mixed population of seeds were screened by 
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PCR using the primers P1+P3. The wild-type allele was amplified using P2+P3; 
Supplemental Table 1 in Appendix B.   
4.3.4 Sphingolipid Extraction and Analysis  
Sphingolipids were extracted as described in Markham and Jaworski (2007). Briefly, 35-
d-old Arabidopsis leaves were collected for biological replicates. The plant tissue was 
lyophilized, and 10 to 30 mg of tissue was homogenized and extracted with 
isopropanol:heptane:water (55:20:25, v/v/v). Internal standards for the different 
sphingolipid classes were added. The supernatants were dried and de-esterified with 
methylamine in ethanol:water (70:30, v/v). The lipid extract was re-suspended in 
tetrahydrofuran:methanol:water (5:2:5, v/v/v) containing 0.1% (v/v) formic acid. The 
sphingolipid species were analyzed using a Shimadzu Prominence ultra-performance 
liquid chromatography system and a 4000 QTRAP mass spectrometer (AB SCIEX). Data 
analysis and quantification were performed using the software Analyst 1.5 and 
MultiQuant 2.1 as described by Markham and Jaworski (2007) and Kimberlin et al. 
(2013). 
4.3.5 Alanine and Fumonisin B1 Treatment 
 Selected red seeds were sown on MS medium supplemented with 5 mM Alanine (Acros 
Organics) or 0.4 µM Fumonisin B1 (Sigma).  
4.3.6 RNA Isolation and Quantitative RT-PCR  
RNA was extracted from 12- to 15-d-old Arabidopsis seedlings grown on solid MS 
medium. Each replicate corresponds to pooled seedlings from independent plates. RNA 
extraction was performed using an RNeasy Kit (Qiagen) according to the manufacturer’s 
protocol. The isolated RNA (1mg) was treated with DNase I (Invitrogen). cDNA 
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conversion was performed with a RevertAid cDNA synthesis kit (Thermo Fisher 
Scientific). SYBR Green was used as the fluorophore in a qPCR supermix (Qiagen). 
PP2AA3 was used as internal reference genes. qPCR was performed using a Bio-Rad 
MyiQ iCycler qPCR instrument. The thermal cycling conditions were an initial step of 
95°C for 10 min followed by 45 cycles at 95°C for 15 s, 60°C for 30 s, and 72°C for 30 s. 
Primers used in this study are listed in Supplemental Table 1, Appendix B. 
4.4 Results 
4.4.1 SPT Amino Acids Associated with HSAN1 are Conserved in Arabidopsis 
Two frequent mutations that cause HSAN1 in humans are C133W and V144D. The 
human SPTLC1 and Arabidopsis LCB1 share 44 % identity with each other. Based on 
the sequence alignment Cysteine 144 in Arabidopsis corresponds to C133 in human 
SPTLC1 and it is located in a conserved region (Figure 4.1). Similarly, the Valine residue 
in position 155 that corresponds to V144 in human. Mutating the Cysteine to Tryptophan 
and Valine to Aspartic acid, should confer the structural shift to allow the use of alanine 
and glycine to generate deoxysphingolipids.   
 
Figure 4.1 Partial alignment of Arabidopsis thaliana AtLCB1 and Homo sapiens HsSPTLC1 protein 
sequences. 
The arrows indicate two residues associated with HSAN1 phenotype, C133 and V144 in human and the 




Given that the complete knockout of LCB1 is lethal (Chen et al., 2006), for this study we 
sought to complement the LCB1 heterozygous mutants with a construct expressing 
LCB1C144W or LCB1C144W/V155D under the native LCB1 promoter. In a previous work it 
was showed that a construct containing the wild-type AtLCB1 under the control of the 
upstream native promoter was sufficient to complement the SALK_077745 T-DNA 
mutant (Chen et al., 2006). With a successful complementation we would expect the 
levels of deoxysphingolipids to accumulate and this could be used as strategy to measure 
SPT activity.  However, after three and four generations complementation was not 
achieved (Tables 1 and 2; Supplemental Figure 1 in Appendix B). Therefore, the rest of 
the experiments in this study were performed using transgenic lines expressing the 
mutated LCB1 versions in a wild-type or a heterozygous background. Considering that 
these mutations are dominant in the context of HSAN1 (Dawkins et al., 2001), we expect 
that even with a copy of the wild-type LCB1 the mutated version will still promote the 
generation of deoxysphingolipids.  
Table 1 Segregation analysis of progeny from LCB1C144W transgenic lines  
Progeny Genotype  (Observed/Total) 
Parent 


















Table 2 Segregation analysis of progeny from LCB1C144W V155D transgenic lines  
 
Progeny Genotype  (Observed/Total) 
Parent 




























4.4.2 Arabidopsis HSAN1 Mutants Showed Early Senescence, Delayed Flowering 
and Resistance to FB1.   
To examine the phenotype of the transgenic lines, seeds were grown in solid MS 
medium. Both lines tested showed low germination rates ~26 % when expressing 
LCB1C144W and ~ 54 % for LCB1C144W/V155D. Moreover, the transgenic seedlings 
developed pale/yellow leaves compared to the wild type (Figure 4.2A). We also observed 
pale wild-type seedlings growing on medium supplemented with alanine and a stronger 
effect on the transgenic plants (Figure 4.2B).  
 
 
Figure 4.2 Representative images of 15-day-old wild-type, LCB1C144W and LCB1C144W/V155D seedlings. 
(A) MS medium, (B) MS medium supplemented with 5 mM Alanine, and (C) MS medium supplemented 
with 0.4 µM FB1.  
 
Interestingly, even though wild-type plants were sensitive to FB1, the seedlings 
expressing LCB1 with mutations showed resistance to the toxin but still showed pale-
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yellow leaves (Figure 4.2C). When transferred to soil the transgenic plants recovered the 
green appearance but showed delayed flowering and early senescence features (Figure 
4.3 A and Supplemental Figure 1 in Appendix B).  
Chlorotic and green leaves were used for sphingolipid extractions to measure the 
canonical species and deoxyceramides. Sphingolipid profiling revealed that, even though 
there was not a significant change in the levels of m18:0 and m18:1-containing ceramides 
compared to wild type these deoxyLCBs were preferentially coupled with C16 fatty acids 
(Figure 4.3B). In addition, the chlorotic leaves accumulated C16 fatty acid containing-
ceramides compared to the normal green leaves (Figure 4.3C).  
  
 
Figure 4.3 Ceramides and Deoxyceramides Profiles. 
(A) Forty-day old wild-type plants and transgenic lines expressing LCB1C144W and LCB1C144W/V155D.  
Ceramide molecular species compositions representing the exact pairings of LCB and fatty acid for the 
wild-type and the indicated transgenic lines in (B) green leaves and in (C) yellow/pale leaves. Shown are 
representative values of one plant or the mean ± SD n=3. 
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4.4.3 Expression of Genes Associated with Senescence and Sphingolipid 
Biosynthesis and Homeostasis   
 
 
Figure 4.4 Expression of Genes Associated with Senescence and Sphingolipid Biosynthesis, 
Catabolism, and Homeostasis. 
15 day-old wild-type plants and transgenic lines expressing LCB1C144W and LCB1C144W/V155D, were used to 
examine gene expression by q-PCR to monitor the expression of (A) senescence-related 13 SAG13, (B) 
ceramide synthase LOH2 (C) ORM1 (D) ORM2 and (E) DPL1. PP2AA3 transcript levels were used as a 
control. Specific primers used for this analysis are shown in Supplemental Table 1 in Appendix B. Gene 
expression levels are normalized to those in wild-type seedlings. Values are the mean ± SD (n=9). There 
are no significant differences based on one-way ANOVA followed by Tukey´s multiple comparisons test.  
 
Given that the plants expressing HSAN1-like mutations showed early senescence and 
accumulation of C16 ceramides we then examined the expression SAG13, a senescence-
related gene, and LOH2, the gene encoding the ceramide synthase that preferentially N-
acylates C16 fatty acids with LCBs to form ceramides. Our results revealed no significant 
changes in the expression of these genes among the wild-type and transgenic lines 
evaluated (Figures 4.4A and 4.4B). Similarly, the expression of ORM genes, regulators of 
SPT activity; and DPL1, encoding the lyase that catabolizes LBCs, did not change in the 





For this work, we hypothesized that the incorporation of the HSAN1 mutations into the 
Arabidopsis LCB1 SPT subunit would enhance the production of deoxysphingolipids in 
the plants. DeoxySA (m18:0) is normally present at very low concentrations in the wild-
type and can be increased 60-fold in the orm1∆met/∆met orm2−/− mutant where SPT activity 
is deregulated (Chapter 3). We picked C144W and V155D because they are among the 
most frequent mutations in the context of HSAN1 and these residues are in a highly 
conserved region of LCB1 that is predicted to be a catalytic domain (Bode et al., 2016). 
Failure to complement the Atlcb1+/− mutant with LCB1C144W or LCB1 C144W/V155D 
suggests the detrimental effects of these point mutations. Additional confirmation was 
provided by the low germination rate of the progeny of heterozygous plants expressing 
the mutations in LCB1. Notably, the germinated seeds gave rise to plants with an early 
senescence phenotype, which was also observed in wild-type seedlings growing with 
alanine supplementation. It has been shown that the formation of deoxysphingolipids is 
modulated by the availability of alanine and serine. Increased alanine concentration 
enhances the production of deoxysphingolipids in a HSAN1 mouse model and in mutant-
expressing HEK293 cells (Garofalo et al., 2011; Bode et al., 2016). Therefore, one 
possible explanation is that wild-type SPT can use alanine as substrate for the production 
of deoxysohingolipids when this amino acid is in excess. In this context it will be 
important to perform sphingolipid measurements for the detection of the free deoxyLCBs 
(m18:0, m18:1) and their incorporation into ceramides in seedling grown with excess 
alanine and serine. In this case, we would expect serine enrichment to alleviate the 
senescence phenotype in the transgenic plants. 
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Our findings showed that the senescence phenotype persisted in adult transgenic plants 
and it was also associated with delayed flowering. Despite the observed phenotypes, the 
adult transgenic plants did not accumulate deoxyceramides compared to wild type. Yet, 
the detected deoxyLCBs were preferentially coupled with C16 fatty acids to form 
deoxyceramides. This suggests channeling through the LOH2 ceramide synthase which 
has substrate specificity for the more common dihydroxy LCBs. In contrast, mouse 
fibroblasts incorporated supplemental m18:0 to a variety of acyl-CoAs from C16 to 
C24:1; while m18:1 was preferentially acylated to VLCFA (Alecu et al., 2017). 
Examination of gene expression showed no changes in LOH2 transcript levels in the 
transgenic plants compared to wild type; perhaps other regulatory mechanisms at the 
protein level could take place to favor the increase of C16 ceramides in chlorotic leaves. 
Moreover, it will be interesting to determine if C16 ceramide accumulation also occurs 
during senescence in wild-type plants.  
Consistent with our findings, in mammalian cells the HSAN1-like mutations have been 
linked to the aging process and induced expression of senescence markers (Lone et al., 
2019). Even though, gene expression analyses showed no differences in the transcript 
levels of the senescence-related gene SAG13, it is necessary to complement the analysis 
with other markers.  
Until recently, deoxysphingolipids have been considered dead-end metabolites due to the 
lack of the hydroxyl group at C1 position for canonical degradation. However, a recent 
report described multiple polyunsaturated and polyhydroxylated forms of deoxySA as 
catabolic downstream products (Alecu et al., 2017). It is possible that in plants 
deoxysphingolipids are also degraded to other hydroxylated structures as a cellular 
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detoxification process that requires further investigation. Another important aspect 
related to the cellular effects of deoxysphingolipids is their subcellular localization.  
A study revealed that an alkyne-click labelled deoxySA initially localizes to 
mitochondria and it is later detected in Golgi and ER (Alecu et al., 2017). The 
localization of these lipids to mitochondria induces changes in morphology and reduced 
ATP generation (Alecu et al., 2017).  Future work will focus on determining possible 
downstream products of deoxysphingolipids in plants and their potential roles related to 
mitochondrial dysfunction and senescence.  
It is important to note that the effect of two HSAN1-related mutations, like in LCB1 
C144W/V155D, has not been investigated before; however, our current findings suggest there 
is no synergistic effect when compared to the single mutation LCB1 C144W. 
Out of the context of HSAN1, mammalian cells treated with FB1, a ceramide synthase 
inhibitor, accumulated deoxySA showing that wild-type SPT was able to synthesize this 
unusual structures (Zitomer et al., 2011). Moreover, FB1 treatment caused an increase in 
deoxySA in HEK293 cells expressing SPTLC1C133W and this was accompanied with a 
reduced SPT activity (Bode et al., 2016). Consistent with this, our results showed 
transgenic seedlings expressing LCB1C144W and LCB1 C144W/V155D were resistant to the 
cell death induced by FB1, possibly due to a decrease in SPT activity and reduced levels 
of canonical cytotoxic LCBs. In order to elucidate if ORM proteins could be associated 
with SPT regulation under FB1 treatment, we performed gene expression analyses. Our 
results rule out the possibility of transcriptional regulation of ORM, but leave open other 
options like specific ceramide species interacting with ORMs to exert the regulation of 
SPT activity.  
89 
 
One of the objectives of the present study was to introduce the HSAN1 mutations in the 
Arabidopsis LCB1 to examine the feasibility of using deoxySA levels as a readout for 
SPT activity. In yeast, this strategy has been successful and the concentration of this 
atypical LCB has been used as an indirect measurement of activity (Gable et al., 2010). In 
the case of Arabidopsis, more work is needed to determine if the free deoxyLCBs 
(m18:0, m18:1) can be used for this purpose. Especially, it will be important to determine 
the dynamics of the catabolic pathways.  In addition, it will be interesting to explore if the 
ORM proteins are involved in the regulation of SPT activity in response to the production 
of deoxysphingolipids. 
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5 Chapter 5 Towards Building a Kinetic Model of Sphingolipid Biosynthesis 
under FB1 Treatment and Pathogen Infection.  
This chapter may be part of a publication in the future.  
Authors: Ariadna Gonzalez Solis, Adil Alsiyabi, Jennifer E. Markham, Edgar B. Cahoon, 
Rajib Saha. 
5.1 Abstract  
The fungal mycotoxin FB1 and the avirulent pathogen Pseudomonas syringae pv. tomato 
avrRpm1 elicit a rapid increase in LCBs and their phosphorylated forms in Arabidopsis. 
In the case of FB1 treatment, this buildup of LCBs is the consequence of the inhibition of 
ceramide synthases that condense LCBs and fatty acids for the formation of ceramides. In 
contrast, the main mechanisms of the accumulation of LCBs are not known during 
pathogen infection. Here we characterize the Arabidopsis cell suspension culture as a 
system for the generation of a metabolic model that will allow a better understanding of 
the changes in sphingolipid network in the context of FB1 treatment and pathogen 
infection.  
5.2 Introduction 
In addition to the structural roles of glycosphingolipids (GlcCer and GIPCs) in membrane 
formation and function; sphingolipid biosynthetic intermediates (LCBs and ceramides) 
have been recognized as important mediators of physiological processes in plants. 
Phosphorylated long chain bases (LCBs-P) participate in the ABA-mediated signaling 
pathway that regulate stomatal closure (Ng et al., 2001; Coursol et al., 2003, 2005; 
Townley et al., 2005). Whereas several studies revealed LCBs and ceramides as inducers 
of programmed cell death (PCD). This association has been shown in Arabidopsis 
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mutants that accumulate ceramides (Liang et al., 2003; Bi et al., 2014); with exogenously 
applied LCBs and ceramides (Lachaud et al., 2010, Alden et al., 2011) or with Fumonisin 
B1 (FB1) treatment (Stone et a., 2000; Shi et al., 2007; Saucedo-García et al., 2011).  
FB1 is a sphingosine-analogue mycotoxin produced by Fusarium species. It is widely 
known as a potent inhibitor of ceramide synthases that triggers the accumulation of LCBs 
(Abbas et al., 1994). Recent evidence suggests this mycotoxin exerts a more effective 
inhibition on Class II ceramide synthases (LOH1 and LOH3) that generate ceramides 
with VLCFA, than Class I (LOH2) which preferentially produces C16-containing 
ceramides (Markham et al., 2011; Ternes et al., 2011; Luttgeharm et al., 2016). 
Therefore, the PCD induced by FB1 is presumably due to the accumulation of LCBs and 
C16 ceramides.     
A successful immune response in plants often includes the hypersensitive response (HR), 
a form of rapid programmed cell death (PCD) occurring in a limited area at the site of 
infection (Balint-Kurti, 2019). This suicide of infected cells is thought to limit the spread 
of biotrophic pathogens that rely on the plant cell machinery for proliferation (Mur et al., 
2010). Given the similarities of FB1- and pathogen- induced PCD it is believed that 
LCBs and ceramides are part of the large array of signaling networks involved in plant 
resistance (Berkey, 2012). Notably, infection of Arabidopsis with the avirulent pathogen 
Pseudomonas syringae pv. tomato avrRpm1 triggers the accumulation of LCB 
phytosphingosine (t18:0) (Peer at al., 2010). Furthermore, the ceramide accumulation in 
acd5 and acd11 mutants is associated with salicylic acid- dependent upregulation of 
defense-related genes (Brodersen et al., 2002). However, the mechanisms for the 
induction of LCB and ceramides during pathogen attack are not known. It is possible that 
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the immune response mechanisms are linked to an altered regulation of SPT to induce de 
novo synthesis of sphingolipids (Takahashi et al., 2009). Alternatively, catabolic 
reactions including the degradation of more complex sphingolipids like GIPCs and 
GlcCer could give rise to enhanced levels of free LCBs and ceramides.  
In this work, we characterized the Arabidopsis T87 cell line as a system to perform 
metabolic labeling to determine the changes in sphingolipid levels in response to FB1 and 
pathogen infection. This system will be used to generate data to create a kinetic model 
that will allow a better understanding of the changes in the metabolic network. The 
combination of experimental testing and in silico analysis will allow refinement of the 
model to make predictions of cell responses under different perturbations. 
5.3 Materials and Methods  
5.3.1 Plant Material and Growth Conditions.  
An undifferentiated and photoautotrophic Arabidopsis thaliana T87 cell suspension 
culture, established from the ecotype Columbia (Axelos et al., 1992), was used in this 
study. Cells were cultured in NT-1 liquid medium (Murashige and Skoog medium with 
vitamins, 30 g/l sucrose, 1 mM KH2PO4, 1mg/l thiamine, 100mg/l myo-inosytol and 
2 µM 2,4-dichlorophenoxyacetic, pH 5.8 adjusted with KOH) at 22 °C and 120 rpm on a 
shaking platform under continuous light conditions (100µmol/ m-2 s-1).  Every 7 days 1 
ml of mother cell suspension was transferred into 50 ml of fresh medium. 
5.3.2 Stable Isotope Labeling  
T87 Arabidopsis cells were cultured in NT-1 liquid medium containing 




5.3.3 Fumonisin B1 Treatment 
The cells were grown for 2 d first in NT-1 medium and then FB1 (Sigma-Aldrich) was 
added for a final concentration of 1µM. The cells were sampled for analysis after 1, 2, 4, 
6, 12, 24, 48 and 72 h. Control cells were also sampled at the same point of time. Cells 
were harvested by centrifugation at 400g for 5 min and lyophilized prior to sphingolipid 
analysis.  
5.3.4 Sphingolipid Extraction and Analysis.  
Sphingolipids were extracted as described in Markham and Jaworski (2007). Briefly, 10 
to 30 mg of lyophilized cells were homogenized and extracted with 
isopropanol:heptane:water (55:20:25, v/v/v). Internal standards for the different 
sphingolipid classes were added. The supernatants were dried and deesterified with 
methylamine in ethanol:water (70:30, v/v). The lipid extract was re-suspended in 
tetrahydrofuran:methanol:water (5:2:5, v/v/v) containing 0.1% (v/v) formic acid. The 
sphingolipid species were analyzed using a Shimadzu Prominence ultra-performance 
liquid chromatography system and a 4000 QTRAP mass spectrometer (AB SCIEX). The 
incorporation of the 15N into sphingolipid was detected with a +1 m/z shift in the mass of 
both the precursor and the product ion in sphingolipid MRMs. Data analysis and 
quantification were performed using the software Analyst 1.5 and MultiQuant 2.1 as 
described by Markham and Jaworski (2007), Kimberlin et al. (2013).  
5.4 Results  
A time-course sphingolipid profiling was conducted to characterize the response of the 
Arabidopsis cells to FB1. The accumulation of free LCBs was observed from two hours 
of treatment with the mycotoxin and was sustained over all the time points analyzed 
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(Figures 5.1A-C and 2A-H). Free LCBs, mainly d18:0 and t18:0, accumulated 17-fold 
during the first six hours of treatment compared to the control (Figure 5.1A-C and 5.2A-
D). While after 24, 48 and 72 hours, the phosphorylated forms (LCB-P), d18:0-P and 
t18:0-P, reached levels of 36- 203- and 280-fold, respectively, compared to the control 
(Figures 5.1B-C and 5.2A-H). In addition, treatment with FB1 resulted in a reduction of 
~half the amount of the original level of ceramides at two hours and was maintained until 
six hours post treatment. We observed an increase in C16 ceramides at 24 hours after 
exposure to FB1.    
 
Figure 5.1 Time course sphingolipid profiling of Arabidopsis T87 cells after treatment with 1µM 
FB1. 
(A) Total levels of free LCBs and the phosphorylated forms (LCB-P). Distribution of free or 
phosphorylated LCBs at the different time points analyzed for (B) control and (C) 1µM FB1. (D) Total 
levels of ceramides. Distribution of ceramides containing (E) very long chain fatty acids (VLCFA) or (F) 




To establish if the stable isotope labeling with 15N is a suitable method to detect changes 
in fluxes of sphingolipids, we first determined the growth rate of the Arabidopsis cells in 
medium where the nitrogen sources have been replaced with 15N. According to the results 
the 15N medium did not affect the growth of the cells (Figure 5.3A). Next, to determine if 
we can detect the label going to sphingolipids we measured labeled LCBs and ceramides 
after 18 hours of growing in 15N medium. We observed an incorporation of the isotope 




Figure 5.2 Time course profiling of LCBs and LCB-P. 
Time course analysis of the indicated (A-D) free LCBs and (E-H) phosphorylated LCBs (LCB-P) levels in 





Figure 5.3 Labeling of Sphingolipids with the Stable Isotope Nitrogen 15. 
(A) Growth curve of T-87 cells cultured with nitrogen 14 (14N) or the stable isotope nitrogen 15 (15N). 
Values are the mean ±SD (n=3). (B) Incorporation of 15N into ceramides and LCBs of wild type cultured 
cells treated with DMSO as control and 1 nM myriocin for 18 hours. Values are the mean ±SD (n=3).  
Asterisks denote statistical significance when P < 0.01 in Students' T Test. 
 
5.5 Discussion  
For our studies, we chose the photoautotrophic Arabidopsis T87 cell culture because it 
has a short doubling time (2.7 days), produces large amount of tissue and it is a good 
system to perform in vivo labeling with reduced biological variation.  
Consistent with previous studies performed in plants (Saucedo-Garcia et al., 2011; Peer et 
al., 2010), treatment of the Arabidopsis cell suspension with FB1 elicited a rapid 
accumulation of free LCBs and the phosphorylated forms. Moreover, as expected, we 
observed a reduction in ceramide levels following FB1 exposure and a subsequent 
accumulation of C16 ceramides at longer times (>24 h). These results confirm the early 
response of the cells to FB1 and validate it as a good system for the labeling studies. 
We could also detect the incorporation of the nitrogen 15 isotope into LCBs and 
ceramides via flux through SPT in short-term experiments, thus this is a cost effective 
and accurate procedure that can be used in quantitative profiling to apply to a kinetic 
model. The rate at which 15N appears in sphingolipids will be used to calculate the fluxes 
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trough each step of the pathway using a reaction network that comprises all the metabolic 
transformations involved in sphingolipid biosynthesis in Arabidopsis (Alsiyabi et al., 
2010 under revision). Especially, this labeling approach will be very informative to 
estimate sphingolipid turnover rates. The kinetic model will allow us to make predictions 
of how the flux of sphingolipid metabolites is regulated in response environmental 
responses.  
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6 APPENDIX A 
 
 
Supplemental Figure 1. Predicted Protein Sequences of ORMs in the CRISPR/Cas9 Mutants.    
 
Predicted protein sequences based on indels. (A) ORM1, for the single mutant orm1−/− and the double 
knockout orm1−/− orm2−/−, the deletion of one nucleotide in the first exon resulted in a frameshift in the 
coding sequence that produced premature termination. In the case of orm1∆met/∆met orm2−/− the deletion of 
three nucleotides resulted in the elimination of a methionine residue at position 51. (B) ORM2, for the 
single mutant orm2−/− and double mutants, the deletion of four nucleotides caused a frameshift and 










Supplemental Figure 2. PCR/Digestion-based Genotyping of CRISPR/Cas9 ORM Mutants. 
 
The DNA fragment encompassing the CRISPR target site was amplified by PCR (Primers P5-P8) and 
digested with BslI (ORM1) or DraIII (ORM2).  
(A) Representative genotyping results of wild-type Col-0 and orm1+/−  orm2+/−.   
(B) Representative genotyping results of wild-type Col-0, orm1−/−, orm2−/−, orm1∆met/∆met orm2+/−  and 
orm1∆met/∆met orm2−/−.  In wild-type plants, the DNA is completely digested at the restriction site. In 
homozygous plants, the restriction site was lost by CRISPR/Cas9-induced mutation, resulting in undigested 


















Supplemental Figure 3. Complementation of orm1met/met orm2−/−. 
 
(1) Wild-type plant, (2-8) orm1∆met/∆met orm2−/− plants complemented with a codon optimized version of 























Supplemental Figure 4. Ceramide Compositions with Hydroxylated Fatty Acids in ORM Mutants. 
 
Concentrations of ceramides with hydroxylated fatty acids (hCer) are presented according to the 
composition of LCB (d18:0, d18:1, t18:0, t18:1) and hydroxylated (h) fatty acid for (A) wild-type Col-0, 
(B) orm1−/−, (C) orm2−/−, (D) orm1∆met/∆met orm2+/− and (E) orm1∆met/∆met orm2−/−. Bars show averages of four 
to six replicates consisting of 12 to 15-day-old pooled seedlings grown on different plates. Error bars 













Supplemental Figure 5. Glucosylceramide Compositions in ORM Mutants.   
 
Glucosylceramide (GlcCer) concentrations are presented according to the composition of LCB (d18:0, 
d18:1, t18:0, t18:1) and hydroxylated (h) fatty acid for (A) wild-type Col-0, (B) orm1−/−, (C) orm2−/−, (D) 
orm1∆met/∆met orm2+/− and (E) orm1∆met/∆met orm2−/−. Bars show averages of four to six replicates consisting of 
12 to 15-day-old pooled seedlings grown on different plates. Error bars represent the standard error of the 

















Supplemental Figure 6. Composition of Glucosylceramides Containing Non-Hydroxylated Fatty Acids in 
ORM Mutants.   
 
Concentrations of glucosylceramides containing non-hydroxylated fatty acids (nh-GlcCer) are presented 
according to the composition of LCB (d18:0, d18:1, t18:0, t18:1) and fatty acid for (A) wild-type Col-0, (B) 
orm1−/−, (C) orm2−/−, (D) orm1∆met/∆met orm2+/− and (E) orm1∆met/∆met orm2−/−. Bars show averages of four to 
six replicates consisting of 12 to 15-day-old pooled seedlings grown on different plates. Error bars 
















Supplemental Figure 7. Glycosylinositolphosphoceramide Compositions in ORM Mutants.  
 
Glycosylinositolphosphoceramide (GIPC) concentrations are presented according to the composition of 
LCB (d18:0, d18:1, t18:0, t18:1) and the hydroxylated (h) fatty acid for (A) wild-type Col-0, (B) orm1−/−, 
(C) orm2−/−, (D) orm1∆met/∆met orm2+/− and (E) orm1∆met/∆met orm2−/−. Bars show averages of four to six 
replicates consisting of 12 to 15-day-old pooled seedlings grown on different plates. Error bars represent 






Supplemental Figure 8. Expression of Genes Associated with Sphingolipid Biosynthetic and Catabolic 
Pathways and Pathogenesis.   
 
Wild-type, orm1−/−, orm2−/−, orm1∆met/∆met orm2+/−  and orm1∆met/∆met orm2−/−seedlings (12-day-old plants) 
were used to examine gene expression by qPCR to monitor genes encoding enzymes in the sphingolipid 
biosynthetic and catabolic pathways: (A) LCB1, (B) ssSPTa, (C) ceramide synthase gene LOH1, (D) 
sphingosine kinase 1 gene SPHK1; and the selected pathogenesis-related gene (E) basic chitinase PR3. 
PP2AA3 transcript levels were used as a control for the sphingolipid genes and UBIQUITIN for the 
pathogenesis-related genes. Specific primers used for this analysis are shown in Supplemental Table 1. 
Gene expression levels are normalized to those in wild-type seedlings. Values are the mean ± SD (n=6-12). 
Different letters indicate significant difference based on one-way ANOVA followed by Tukey’s multiple 




Supplemental Figure 9. Amino Acid Sequence Alignment of ORM Proteins. 
 
Protein sequences from Saccharomyces cerevisiae (Sc), Arabidopsis thaliana (At) and Homo sapiens 
(ORMDL). The dashed lines indicate putative transmembrane domains. Methionine 51 in AtORM1 is 












































P5 ORM1-F 5’-GAAATGGCGAATCTGTATG-3’ Genotypin
g  
P6 ORM1-R 5’-CATCATCTAATTTAAAGTCAC-3’ Genotypin
g 
P7 ORM2-F 5’-CTTGCTCAACGACGATTCAT-3’ Genotypin
g 
P8 ORM2-R 5’-GAGGAGATCGGGAATAATAC-3’ Genotypin
g 
P9 Cas9-F 5’-CTGTTCGTCGAGCAGCACAAGCATT-3’ Cas9 check 

























QuantiTect Qiagen QT00857220 qPCR 
P18 LOH1 
(At3g25540) 





QuantiTect Qiagen QT00774949  qPCR 
P20 LOH3 
(At1g13580) 
QuantiTect Qiagen QT00857402 qPCR 
P21 LCB1 
(At4g36480) 




QuantiTect Qiagen QT01712004 qPCR 
P23 DPL1qpcr-F  5’-GCTTGGTCAACTGGCTCTTA-3’ qPCR 
P24 DPL1qpcr-R 5’-GGGATCTGGTACCCAAGTTTAC-3’ qPCR 
P25 Sphk1-qpcr-F 5’-AGACCTTGGTTGAGAAAGGAGGAG-3’ qPCR 
P26 Sphk1-qpcr-R GATGGAACTTATCGGACCAAAGCT qPCR 
P27 Sphk2-qpcr-F CGGTGGACAGAGTATGGACTCC qPCR 
P28 Sphk2-qpcr-R GCAGCAGATTCCTCCTGCCT qPCR 
P29 PRXc-qpcr-F 5’-CAACATCGTCCACTTGGACAATCTT-3’ qPCR 
P30 PRXc-qpcr-R 5’-CCTGCCAAAGTGACAGATTGTTGAG-3’ qPCR 
P31 PR2-qpcr-F 5’-AGCCTCACCACCAATGTTGATGAT-3’ qPCR 
P32 PR2-qpcr-R 5’-GTTCTCGATGTTCTGCATTGCTTGT-3’ qPCR 
114 
 
P33 PR3-qpcr-F 5’-AACGGTCTATGCTGCAGCGAGTT-3’ qPCR 
P34 PR3-qpcr-R 5’-GCGCTCGGTTCACAGTAGTCTGA-3’ qPCR 
P35 FMO-qpcr-F 5’-CGTATTCGAAGCCTCGGATTCAGTC-3’ qPCR 
P36 FMO-qpcr-R 5’-GGTATTCTTGGAACGTCGCCGTATT-3’ qPCR 





































7 APPENDIX B 
 
 
Supplemental Figure 1. Amplification with gene specific primers (P2+P3 Supplemental Table 1, 
Appendix B) indicate wild type LCB1, while amplification with T-DNA primers (P1+P3) indicate the 
presence of the T-DNA. A PCR product amplified with both primer sets indicates heterozygous line. 








































P1 Lb1a 5’-TGGTTCACGTAGTGGGCCATCG-3’ 
 
Genotyping  
P2 F1 5’-GATGGCTTCATGTAATGTTTGTACTTTC-3’ 
 
Genotyping 





QuantiTect Qiagen QT00857220 qPCR 
P5 LOH2 
(At3g19260) 
















P10 ORM2-qPCR-F 5’-TTGATAATGGCAAGCAGCTTACACGTA-3’ 
 
qPCR 
P11 ORM2-qPCR-R 5’-
ATCAAGTACAAGACAACAGGAACAACGG-3’ 
 
qPCR 
 
 
 
 
 
 
 
 
 
 
 
